Cooperation	O
between	O
core	B-protein
binding	I-protein
factor	I-protein
and	O
adjacent	B-DNA
promoter	I-DNA
elements	I-DNA
contributes	O
to	O
the	O
tissue-specific	O
expression	O
of	O
interleukin-3	B-protein
.	O

Tissue-specific	O
expression	O
of	O
interleukin-3	B-protein
(	O
IL-3	B-protein
)	O
is	O
mediated	O
via	O
cis-acting	B-DNA
elements	I-DNA
located	O
within	O
315	O
base	O
pairs	O
of	O
the	O
transcription	B-DNA
start	I-DNA
.	O

This	O
is	O
achieved	O
in	O
part	O
through	O
the	O
positive	O
activities	O
of	O
the	O
AP-1	B-DNA
and	I-DNA
Elf-1	I-DNA
sites	I-DNA
in	O
the	O
IL-3	B-DNA
promoter	I-DNA
.	O

The	O
contribution	O
to	O
T	O
cell-specific	O
expression	O
by	O
other	O
promoter	B-DNA
sites	I-DNA
was	O
assessed	O
in	O
a	O
transient	O
expression	O
assay	O
with	O
IL-3	B-DNA
promoter	I-DNA
constructs	I-DNA
linked	O
to	O
a	O
luciferase	B-DNA
gene	I-DNA
,	O
focusing	O
initially	O
on	O
the	O
core	B-DNA
binding	I-DNA
factor	I-DNA
(	I-DNA
CBF	I-DNA
)	I-DNA
site	I-DNA
,	O
which	O
is	O
footprinted	O
in	O
vivo	O
upon	O
T	O
cell	O
activation	O
.	O

Activity	O
of	O
the	O
CBF	B-DNA
site	I-DNA
is	O
shown	O
to	O
be	O
critically	O
dependent	O
on	O
the	O
adjacent	B-DNA
activator	I-DNA
site	I-DNA
Act-1	I-DNA
.	O

Together	O
the	O
Act-1	B-DNA
and	O
CBF	B-DNA
sites	I-DNA
form	O
a	O
functional	B-DNA
unit	I-DNA
(	O
AC	B-DNA
unit	I-DNA
)	O
with	O
dual	O
activity	O
.	O

The	O
AC	B-DNA
unit	I-DNA
is	O
demonstrated	O
to	O
enhance	O
basal	O
activity	O
of	O
promoters	O
both	O
in	O
fibroblasts	B-cell_type
and	O
T	B-cell_type
cells	I-cell_type
.	O

This	O
activity	O
is	O
further	O
inducible	O
in	O
activated	O
T	B-cell_type
cells	I-cell_type
,	O
but	O
not	O
in	O
fibroblasts	B-cell_type
.	O

In	O
addition	O
to	O
the	O
already	O
identified	O
NIP	B-DNA
repressor	I-DNA
site	I-DNA
,	O
evidence	O
is	O
presented	O
for	O
a	O
second	B-DNA
repressor	I-DNA
region	I-DNA
that	O
restricts	O
promoter	O
activity	O
in	O
fibroblasts	B-cell_type
.	O

Finally	O
,	O
a	O
novel	O
positive	B-DNA
regulatory	I-DNA
element	I-DNA
has	O
been	O
mapped	O
in	O
the	O
IL-3	B-DNA
promoter	I-DNA
between	O
nucleotide	O
-180	O
and	O
-210	O
that	O
leads	O
to	O
increased	O
expression	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

Together	O
these	O
results	O
demonstrate	O
that	O
T	O
cell	O
expression	O
of	O
IL-3	B-protein
is	O
not	O
specified	O
by	O
the	O
activity	O
of	O
a	O
single	O
tissue-specific	B-DNA
element	I-DNA
,	O
but	O
instead	O
involves	O
multiple	O
interacting	B-DNA
elements	I-DNA
that	O
provide	O
both	O
specific	O
positive	O
regulation	O
in	O
T	B-cell_type
cells	I-cell_type
and	O
specific	O
negative	O
regulation	O
in	O
fibroblasts	B-cell_type
.	O

THs	NULL
JourNaL	NULL
or	NULL
BroLocicaL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

24	NULL
,	NULL
Issue	NULL
of	NULL
June	NULL
14	NULL
,	NULL
pp	NULL
.	NULL

14020-14027	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Cooperation	NULL
between	NULL
Core	NULL
Binding	NULL
Factor	NULL
and	NULL
Adjacent	NULL
Promoter	NULL
Elements	NULL
Contributes	NULL
to	NULL
the	NULL
Tissue-specific	NULL
Expression	NULL
of	NULL
Interleukin-3*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
August	NULL
10	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
December	NULL
20	NULL
,	NULL
1995	NULL
)	NULL
Douglas	NULL
S	NULL
.	NULL

Taylor	NULL
?	NULL
}	NULL

,	NULL
Jacob	NULL
P.	NULL
Laubach	NULL
,	NULL
David	NULL
G.	NULL
Nathan	NULL
,	NULL
and	NULL
Bernard	NULL
Mathey-Prevot§	NULL
From	NULL
the	NULL
Divisions	NULL
of	NULL
Pediatric	NULL
Hematology	NULL
and	NULL
Oncology	NULL
,	NULL
Dana	NULL
Farber	NULL
Cancer	NULL
Institute	NULL
and	NULL
Children	NULL
's	NULL
Hospital	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
Tissue-specific	NULL
expression	NULL
of	NULL
interleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
is	NULL
mediated	NULL
via	NULL
cis-acting	NULL
elements	NULL
located	NULL
within	NULL
315	NULL
base	NULL
pairs	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
.	NULL

This	NULL
is	NULL
achieved	NULL
in	NULL
part	NULL
through	NULL
the	NULL
positive	NULL
activities	NULL
of	NULL
the	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
sites	NULL
in	NULL
the	NULL
IL-3	NULL
promoter	NULL
.	NULL

The	NULL
contribution	NULL
to	NULL
T	NULL
cell-specific	NULL
expression	NULL
by	NULL
other	NULL
promoter	NULL
sites	NULL
was	NULL
assessed	NULL
in	NULL
a	NULL
transient	NULL
expression	NULL
assay	NULL
with	NULL
IL-3	NULL
promoter	NULL
constructs	NULL
linked	NULL
to	NULL
a	NULL
luciferase	NULL
gene	NULL
,	NULL
focusing	NULL
initially	NULL
on	NULL
the	NULL
core	NULL
binding	NULL
factor	NULL
(	NULL
CBF	NULL
)	NULL
site	NULL
,	NULL
which	NULL
is	NULL
footprinted	NULL
in	NULL
vivo	NULL
upon	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Activity	NULL
of	NULL
the	NULL
CBF	NULL
site	NULL
is	NULL
shown	NULL
to	NULL
be	NULL
critically	NULL
dependent	NULL
on	NULL
the	NULL
adjacent	NULL
activator	NULL
site	NULL
Act-1	NULL
.	NULL

Together	NULL
the	NULL
Act-1	NULL
and	NULL
CBF	NULL
sites	NULL
form	NULL
a	NULL
functional	NULL
unit	NULL
(	NULL
AC	NULL
unit	NULL
)	NULL
with	NULL
dual	NULL
activity	NULL
.	NULL

The	NULL
AC	NULL
unit	NULL
is	NULL
demonstrated	NULL
to	NULL
enhance	NULL
basal	NULL
activity	NULL
of	NULL
promoters	NULL
both	NULL
in	NULL
fibroblasts	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
activity	NULL
is	NULL
further	NULL
inducible	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
fibroblasts	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
already	NULL
identified	NULL
NIP	NULL
repressor	NULL
site	NULL
,	NULL
evidence	NULL
is	NULL
presented	NULL
for	NULL
a	NULL
second	NULL
repressor	NULL
region	NULL
that	NULL
restricts	NULL
promoter	NULL
activity	NULL
in	NULL
fibroblasts	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
novel	NULL
positive	NULL
regulatory	NULL
element	NULL
has	NULL
been	NULL
mapped	NULL
in	NULL
the	NULL
IL-3	NULL
promoter	NULL
between	NULL
nucleotide	NULL
-180	NULL
and	NULL
-210	NULL
that	NULL
leads	NULL
to	NULL
increased	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Together	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
T	NULL
cell	NULL
expression	NULL
of	NULL
IL-3	NULL
is	NULL
not	NULL
specified	NULL
by	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
single	NULL
tissue-specific	NULL
element	NULL
,	NULL
but	NULL
instead	NULL
involves	NULL
multiple	NULL
interacting	NULL
elements	NULL
that	NULL
provide	NULL
both	NULL
specific	NULL
positive	NULL
regulation	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
specific	NULL
negative	NULL
regulation	NULL
in	NULL
fibroblasts	NULL
.	NULL

Interleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
``	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
its	NULL
potent	NULL
biologic	NULL
activity	NULL
,	NULL
IL-3	NULL
gene	NULL
expression	NULL
is	NULL
highly	NULL
regulated	NULL
and	NULL
is	NULL
restricted	NULL
to	NULL
human	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
IL-3	NULL
promoter	NULL
has	NULL
been	NULL
extensively	NULL
studied	NULL
,	NULL
and	NULL
multiple	NULL
regulatory	NULL
elements	NULL
have	NULL
been	NULL
identified	NULL
within	NULL
315	NULL
bp	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
3-6	NULL
)	NULL
.	NULL

These	NULL
elements	NULL
include	NULL
sev-	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
RO1	NULL
DK41758	NULL
(	NULL
to	NULL
B.	NULL
Mathey-Prevot	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

+	NULL
Graduate	NULL
trainee	NULL
in	NULL
cancer	NULL
research	NULL
and	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
T32CAO9172-20	NULL
.	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dana	NULL
Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
44	NULL
Binney	NULL
St.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
617-632-2074	NULL
;	NULL
Fax	NULL
:	NULL
617-632-2085	NULL
;	NULL
E-mail	NULL
:	NULL
douglas_taylor	NULL
@	NULL
macmailgw.dfei.harvard.edu	NULL
.	NULL

§	NULL
Partially	NULL
supported	NULL
by	NULL
funds	NULL
from	NULL
the	NULL
Genetics	NULL
Institute	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL-3	NULL
,	NULL
interleukin-3	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
CBF	NULL
,	NULL
core	NULL
binding	NULL
factor	NULL
;	NULL
GM-CSF	NULL
,	NULL
granulocyte-macrophage-colony-stimulating	NULL
factor	NULL
;	NULL
AML	NULL
,	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
;	NULL
MDS	NULL
,	NULL
myelodyspastic	NULL
syndrome	NULL
;	NULL
nt	NULL
,	NULL
nucleotide	NULL
;	NULL
DMEM	NULL
,	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
;	NULL
TPA	NULL
,	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
;	NULL
AC	NULL
unit	NULL
,	NULL
Act-1	NULL
and	NULL
CBF	NULL
sites	NULL
form	NULL
a	NULL
functional	NULL
unit	NULL
;	NULL
RLU	NULL
,	NULL
relative	NULL
light	NULL
unit	NULL
(	NULL
s	NULL
)	NULL
;	NULL
NIP	NULL
,	NULL
nuclear	NULL
inhibitor	NULL
protein	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

eral	NULL
activator	NULL
sites	NULL
:	NULL
AP-1	NULL
,	NULL
EIf-1	NULL
,	NULL
and	NULL
Act-1	NULL
(	NULL
NFIL3	NULL
)	NULL
;	NULL
a	NULL
repressor	NULL
site	NULL
,	NULL
NIP	NULL
;	NULL
and	NULL
a	NULL
``	NULL
permissive	NULL
``	NULL
site	NULL
that	NULL
binds	NULL
core	NULL
binding	NULL
factor	NULL
(	NULL
CBF	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
individual	NULL
regulatory	NULL
elements	NULL
has	NULL
been	NULL
extensively	NULL
studied	NULL
in	NULL
the	NULL
context	NULL
of	NULL
multiple	NULL
promoters/enhanc-ers	NULL
(	NULL
7-11	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
emphasis	NULL
on	NULL
identifying	NULL
novel	NULL
regulatory	NULL
elements	NULL
has	NULL
prevented	NULL
a	NULL
complete	NULL
understanding	NULL
of	NULL
the	NULL
functional	NULL
interactions	NULL
between	NULL
elements	NULL
already	NULL
identified	NULL
.	NULL

These	NULL
interactions	NULL
are	NULL
important	NULL
as	NULL
they	NULL
represent	NULL
another	NULL
possible	NULL
level	NULL
of	NULL
regulatory	NULL
activity	NULL
and	NULL
may	NULL
in	NULL
part	NULL
specify	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
genes	NULL
despite	NULL
impressive	NULL
similarities	NULL
of	NULL
their	NULL
promoters	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
promoter	NULL
for	NULL
both	NULL
granu-locyte-macrophage-colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
and	NULL
IL-3	NULL
bind	NULL
many	NULL
similar	NULL
proteins	NULL
but	NULL
exhibit	NULL
different	NULL
patterns	NULL
of	NULL
expression	NULL
,	NULL
with	NULL
GM-CSF	NULL
being	NULL
produced	NULL
by	NULL
fibroblasts	NULL
,	NULL
macrophages	NULL
,	NULL
and	NULL
endothelial	NULL
cells	NULL
(	NULL
4	NULL
,	NULL
5	NULL
,	NULL
8	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
particular	NULL
site	NULL
may	NULL
vary	NULL
according	NULL
to	NULL
the	NULL
context	NULL
within	NULL
which	NULL
it	NULL
is	NULL
found	NULL
,	NULL
as	NULL
adjoining	NULL
regulatory	NULL
sites	NULL
may	NULL
modulate	NULL
its	NULL
activity	NULL
(	NULL
4	NULL
,	NULL
12	NULL
)	NULL
.	NULL

The	NULL
IL-3	NULL
promoter	NULL
is	NULL
well	NULL
suited	NULL
to	NULL
address	NULL
possible	NULL
functional	NULL
interactions	NULL
between	NULL
different	NULL
regulatory	NULL
elements	NULL
,	NULL
since	NULL
a	NULL
relatively	NULL
small	NULL
region	NULL
of	NULL
DNA	NULL
contains	NULL
several	NULL
well	NULL
characterized	NULL
sites	NULL
that	NULL
are	NULL
important	NULL
outside	NULL
the	NULL
context	NULL
of	NULL
IL-3	NULL
regulation	NULL
.	NULL

We	NULL
initially	NULL
focused	NULL
on	NULL
the	NULL
normal	NULL
function	NULL
of	NULL
CBF	NULL
,	NULL
since	NULL
mutations	NULL
of	NULL
this	NULL
protein	NULL
complex	NULL
are	NULL
associated	NULL
with	NULL
specific	NULL
subtypes	NULL
of	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
(	NULL
AML	NULL
)	NULL
and	NULL
myelodyspastic	NULL
syndrome	NULL
(	NULL
MDS	NULL
)	NULL
(	NULL
13-17	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
CBF	NULL
site	NULL
and	NULL
adjacent	NULL
Act-1	NULL
element	NULL
form	NULL
a	NULL
regulatory	NULL
unit	NULL
that	NULL
provides	NULL
inducible	NULL
promoter	NULL
activity	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
NIH3T3	NULL
fibroblasts	NULL
.	NULL

We	NULL
also	NULL
demonstrate	NULL
that	NULL
two	NULL
additional	NULL
upstream	NULL
portions	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
inhibit	NULL
promoter	NULL
activity	NULL
in	NULL
NIH3T3	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
an	NULL
initial	NULL
characterization	NULL
of	NULL
a	NULL
previously	NULL
unknown	NULL
positive	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
between	NULL
nt	NULL
-180	NULL
and	NULL
nt	NULL
-207	NULL
is	NULL
provided	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture-The	NULL
human	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
E6.1	NULL
and	NULL
NIH3T3	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
ATCC	NULL
and	NULL
maintained	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
penicillin	NULL
(	NULL
50	NULL
units/ml	NULL
)	NULL
,	NULL
streptomycin	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
RPMI	NULL
complete	NULL
)	NULL
.	NULL

NIH3T3	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
DMEM	NULL
supplemented	NULL
with	NULL
penicillin	NULL
,	NULL
streptomycin	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
pyruvate	NULL
,	NULL
and	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
DMEM	NULL
complete	NULL
)	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
TPA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
0.5	NULL
um	NULL
)	NULL
.	NULL

NIH3T3	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
TPA	NULL
alone	NULL
.	NULL

IL-3	NULL
Promoter	NULL
Constructs-Isolation	NULL
of	NULL
the	NULL
-315-bp	NULL
IL-3	NULL
promoter	NULL
and	NULL
insertion	NULL
into	NULL
an	NULL
IL-3	NULL
reporter	NULL
gene	NULL
has	NULL
already	NULL
been	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
G-C	NULL
mutation	NULL
of	NULL
the	NULL
CBF	NULL
site	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
has	NULL
been	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
guanine	NULL
-139	NULL
,	NULL
-137	NULL
,	NULL
and	NULL
-136	NULL
within	NULL
the	NULL
CBF	NULL
binding	NULL
site	NULL
were	NULL
selectively	NULL
mutated	NULL
to	NULL
cytosine	NULL
using	NULL
standard	NULL
polymerase	NULL
chain	NULL
reaction	NULL
methodology	NULL
.	NULL

This	NULL
mutation	NULL
abrogates	NULL
CBF	NULL
protein	NULL
binding	NULL
.	NULL

Flanking	NULL
HindIII	NULL
sites	NULL
were	NULL
added	NULL
to	NULL
transfer	NULL
the	NULL
full-length	NULL
-815-bp	NULL
promoter	NULL
,	NULL
or	NULL
G-C	NULL
mutant	NULL
(	NULL
-315/GC	NULL
)	NULL
,	NULL
to	NULL
the	NULL
lucif-	NULL
14020	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Functional	NULL
Role	NULL
of	NULL
CBF	NULL
in	NULL
the	NULL
Regulation	NULL
of	NULL
Interleukin-3	NULL
14021	NULL
TaBLE	NULL
I	NULL
Synthetic	NULL
oligonucleotides	NULL
used	NULL
in	NULL
the	NULL
synthesis	NULL
of	NULL
IL-3	NULL
promoter	NULL
constructs	NULL
1A	NULL
:	NULL
synthetic	NULL
oligonucleotides	NULL
used	NULL
to	NULL
insert	NULL
various	NULL
AC	NULL
units	NULL
at	NULL
nt	NULL
-180	NULL
of	NULL
the	NULL
full-length	NULL
(	NULL
-315	NULL
bp	NULL
)	NULL
IL-3	NULL
promoter	NULL
.	NULL

1B	NULL
:	NULL
synthetic	NULL
oligonucleotides	NULL
used	NULL
to	NULL
place	NULL
various	NULL
AC	NULL
units	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
(	NULL
-61	NULL
bp	NULL
)	NULL
IL-3	NULL
promoter	NULL
.	NULL

The	NULL
portion	NULL
of	NULL
the	NULL
oligonucleotide	NULL
sequence	NULL
corresponding	NULL
to	NULL
the	NULL
wild	NULL
type	NULL
or	NULL
mutated	NULL
Act-1	NULL
and	NULL
CBF	NULL
sites	NULL
is	NULL
depicted	NULL
with	NULL
uppercase	NULL
letters	NULL
.	NULL

A	NULL
Oligonucleotide	NULL
Sequence	NULL
AC	NULL
5'-BamH-ctaatggATGAATAATTACGTCTGTGGTTTctag-SstU/Smal-AAC	NULL
5'-BamH-ctaatggATGAATAATTACGTCTCTCCTTTctag-SstU/Smal-AAC	NULL
5'-BamH-ctaatggGGATCCTGTGGTTTtctag-SstUSmal-AAAC	NULL
5'-BamH-ctaatggGGATCCTCTCCTTTtctag-Sstl/Smal-B	NULL
Oligonucleotide	NULL
Sequence	NULL
AC	NULL
5'-Sstl-ccatggATGAATAATTACGTCTGTGGTTTiccc-Smal	NULL
AAC	NULL
5'-Sstl-ccatggATGAATAATTACGTCTCTCCTTTtcce-Smal	NULL
AAC	NULL
5'-Sstl-cTCGAGAAGGTTGGATCCTGTGGTTTtccc-Smal	NULL
erase	NULL
reporter	NULL
gene	NULL
previously	NULL
described	NULL
by	NULL
DeWet	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
-315pL	NULL
,	NULL
-815/GCpL	NULL
)	NULL
(	NULL
19	NULL
)	NULL
.	NULL

An	NULL
independent	NULL
,	NULL
higher	NULL
yield	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
pFlash*	NULL
)	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
pFlash	NULL
vector	NULL
(	NULL
SynapsSys	NULL
Corp.	NULL
,	NULL
Burl-ington	NULL
,	NULL
MA	NULL
)	NULL
by	NULL
excision	NULL
of	NULL
the	NULL
downstream	NULL
polylinker	NULL
between	NULL
Apal	NULL
and	NULL
Smal	NULL
,	NULL
followed	NULL
by	NULL
replacement	NULL
of	NULL
the	NULL
Sstl-Xbal	NULL
(	NULL
luciferase	NULL
nt	NULL
57	NULL
)	NULL
pFlash	NULL
upstream	NULL
polylinker	NULL
with	NULL
the	NULL
equivalent	NULL
fragment	NULL
from	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
,	NULL
pXpl	NULL
(	NULL
pFlash*	NULL
)	NULL
.	NULL

The	NULL
IL-3	NULL
promoter	NULL
was	NULL
then	NULL
inserted	NULL
at	NULL
the	NULL
new	NULL
upstream	NULL
HindIII	NULL
site	NULL
(	NULL
-815pF*/-315/GCpF*	NULL
)	NULL
.	NULL

All	NULL
reporter	NULL
genes	NULL
used	NULL
in	NULL
a	NULL
particular	NULL
experiment	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
same	NULL
root	NULL
plasmid	NULL
.	NULL

Specific	NULL
constructs	NULL
are	NULL
depicted	NULL
schematically	NULL
within	NULL
individual	NULL
figures	NULL
and	NULL
were	NULL
derived	NULL
as	NULL
follows	NULL
.	NULL

A	NULL
second	NULL
CBF	NULL
site	NULL
(	NULL
CBF*	NULL
)	NULL
was	NULL
created	NULL
at	NULL
nt	NULL
-192	NULL
using	NULL
standard	NULL
polymerase	NULL
chain	NULL
reaction	NULL
methodology	NULL
to	NULL
introduce	NULL
a	NULL
C-G	NULL
and	NULL
T-G	NULL
mutation	NULL
at	NULL
nt	NULL
-191	NULL
and	NULL
nt	NULL
-189	NULL
,	NULL
respectively	NULL
.	NULL

Replacement	NULL
of	NULL
the	NULL
DNA	NULL
fragment	NULL
between	NULL
nt	NULL
-180	NULL
and	NULL
nt	NULL
-207	NULL
with	NULL
an	NULL
AC	NULL
unit	NULL
was	NULL
done	NULL
via	NULL
two	NULL
intermediate	NULL
cloning	NULL
steps	NULL
.	NULL

The	NULL
resultant	NULL
promoter	NULL
had	NULL
an	NULL
inserted	NULL
oligonucleotide	NULL
,	NULL
5'-atggATGAATAATTACGTCTGTGGTTT-teta-	NULL
,	NULL
that	NULL
contained	NULL
an	NULL
AC	NULL
unit	NULL
(	NULL
upper	NULL
case	NULL
letters	NULL
)	NULL
in	NULL
place	NULL
of	NULL
the	NULL
27-bp	NULL
Msel	NULL
(	NULL
nt	NULL
-207	NULL
)	NULL
-SauSa	NULL
(	NULL
nt	NULL
-180	NULL
)	NULL
fragment	NULL
in	NULL
the	NULL
-315pL	NULL
expression	NULL
vector	NULL
(	NULL
-315NACpL	NULL
)	NULL
.	NULL

The	NULL
equivalent	NULL
replacement	NULL
was	NULL
made	NULL
in	NULL
an	NULL
IL-3	NULL
promoter	NULL
containing	NULL
a	NULL
G-C	NULL
mutation	NULL
at	NULL
the	NULL
endogenous	NULL
CBF	NULL
site	NULL
(	NULL
-315NAC/GCpL	NULL
)	NULL
.	NULL

AC	NULL
units	NULL
were	NULL
also	NULL
inserted	NULL
at	NULL
nt	NULL
-180	NULL
of	NULL
the	NULL
-3815	NULL
promoter	NULL
in	NULL
-315pL	NULL
to	NULL
create	NULL
promoters	NULL
without	NULL
deletion	NULL
of	NULL
endogenous	NULL
nucleotides	NULL
.	NULL

AC	NULL
cassettes	NULL
contained	NULL
mutations	NULL
in	NULL
none	NULL
,	NULL
one	NULL
,	NULL
or	NULL
both	NULL
members	NULL
of	NULL
the	NULL
AC	NULL
unit	NULL
.	NULL

The	NULL
individual	NULL
cassettes	NULL
were	NULL
synthetic	NULL
oligonucleotides	NULL
obtained	NULL
from	NULL
the	NULL
Dana	NULL
Farber	NULL
Cancer	NULL
Institute	NULL
core	NULL
facility	NULL
(	NULL
Table	NULL
IA	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
AC	NULL
units	NULL
containing	NULL
either	NULL
wild	NULL
type	NULL
or	NULL
mutant	NULL
Act-1	NULL
and	NULL
CBF	NULL
sites	NULL
to	NULL
a	NULL
minimal	NULL
(	NULL
-61	NULL
bp	NULL
)	NULL
IL-3	NULL
promoter	NULL
was	NULL
accomplished	NULL
via	NULL
replacement	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
upstream	NULL
of	NULL
nt	NULL
-61	NULL
with	NULL
one	NULL
of	NULL
the	NULL
synthetic	NULL
oligonucleotides	NULL
summarized	NULL
in	NULL
Table	NULL
IB	NULL
.	NULL

This	NULL
was	NULL
accomplished	NULL
using	NULL
the	NULL
-815pF*	NULL
vector	NULL
digested	NULL
at	NULL
the	NULL
5	NULL
Ssfl	NULL
site	NULL
of	NULL
the	NULL
-315pF*	NULL
polylinker	NULL
and	NULL
the	NULL
3	NULL
``	NULL
Smal	NULL
site	NULL
at	NULL
nt	NULL
-61	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
(	NULL
-61pF*	NULL
)	NULL
.	NULL

This	NULL
construct	NULL
contained	NULL
61	NULL
bp	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
including	NULL
the	NULL
TATA	NULL
box	NULL
at	NULL
nt	NULL
The	NULL
various	NULL
Act-1-CBF	NULL
oligonucleotides	NULL
were	NULL
inserted	NULL
in	NULL
place	NULL
of	NULL
the	NULL
254	NULL
deleted	NULL
nucleotides	NULL
between	NULL
nt	NULL
-61	NULL
and	NULL
nt	NULL
-315	NULL
.	NULL

Intermediate	NULL
length	NULL
IL-3	NULL
promoters	NULL
were	NULL
derived	NULL
from	NULL
-315pF*	NULL
via	NULL
deletion	NULL
of	NULL
upstream	NULL
regions	NULL
of	NULL
the	NULL
promoter	NULL
from	NULL
nt	NULL
-173	NULL
(	NULL
Seal	NULL
)	NULL
,	NULL
nt	NULL
-180	NULL
(	NULL
Sauda	NULL
)	NULL
or	NULL
nt	NULL
-210	NULL
(	NULL
Msel	NULL
)	NULL
.	NULL

All	NULL
constructs	NULL
were	NULL
confirmed	NULL
by	NULL
restriction	NULL
analysis	NULL
.	NULL

Any	NULL
construct	NULL
made	NULL
using	NULL
polymerase	NULL
chain	NULL
reaction	NULL
techniques	NULL
or	NULL
utilizing	NULL
synthetic	NULL
oligonucleotides	NULL
was	NULL
also	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Plasmid	NULL
DNA	NULL
was	NULL
twice	NULL
purified	NULL
over	NULL
cesium	NULL
chloride	NULL
prior	NULL
to	NULL
transfection	NULL
.	NULL

Transient	NULL
Transfection-Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
DNA/1O®	NULL
cells	NULL
using	NULL
either	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
as	NULL
described	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
by	NULL
electroporation	NULL
in	NULL
serum	NULL
free	NULL
conditions	NULL
using	NULL
a	NULL
300-V	NULL
,	NULL
980-uF	NULL
,	NULL
and	NULL
14-ms	NULL
discharge	NULL
(	NULL
PG	NULL
200	NULL
Progenitor	NULL
2	NULL
,	NULL
Hoeffer	NULL
Scientific	NULL
Instruments	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
as	NULL
above	NULL
for	NULL
16	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
TPA	NULL
and	NULL
ionomycin	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
harvested	NULL
6-9	NULL
h	NULL
after	NULL
stimulation	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
(	NULL
Analytical	NULL
Luminescence	NULL
Laboratory	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

NIH3T3	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
DMEM	NULL
supplemented	NULL
as	NULL
above	NULL
and	NULL
transfected	NULL
at	NULL
20	NULL
%	NULL
confluence	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
DNA/1O0	NULL
em	NULL
``	NULL
tissue	NULL
culture	NULL
plate	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Lincoln	NULL
Park	NULL
,	NULL
NJ	NULL
)	NULL
using	NULL
a	NULL
standard	NULL
calcium	NULL
phosphate	NULL
method	NULL
.	NULL

Sixteen	NULL
to	NULL
24	NULL
h	NULL
after	NULL
adding	NULL
CaP	NULL
,	NULL
plates	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
calcium/magnesium-free	NULL
phosphate-buffered	NULL
saline	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
overnight	NULL
in	NULL
fresh	NULL
DMEM	NULL
complete	NULL
prior	NULL
to	NULL
stimulation	NULL
with	NULL
TPA	NULL
.	NULL

Stimulation	NULL
of	NULL
NIHS3T3	NULL
cells	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
TPA	NULL
and	NULL
ionomycin	NULL
decreased	NULL
expression	NULL
of	NULL
all	NULL
reporter	NULL
constructs	NULL
as	NULL
compared	NULL
with	NULL
unstimulated	NULL
or	NULL
TPA-stimulated	NULL
cells	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
obtained	NULL
6-9	NULL
h	NULL
after	NULL
stimulation	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
(	NULL
Analytical	NULL
Luminescence	NULL
Laboratory	NULL
)	NULL
.	NULL

Normalizing	NULL
data	NULL
of	NULL
a	NULL
test	NULL
reporter	NULL
gene	NULL
according	NULL
to	NULL
the	NULL
relative	NULL
activity	NULL
of	NULL
a	NULL
second	NULL
,	NULL
B-galactosidase	NULL
,	NULL
gene	NULL
is	NULL
a	NULL
standard	NULL
methodology	NULL
.	NULL

However	NULL
,	NULL
we	NULL
``	NULL
and	NULL
others	NULL
have	NULL
found	NULL
that	NULL
the	NULL
measured	NULL
B-galactosidase	NULL
activity	NULL
(	NULL
or	NULL
that	NULL
of	NULL
another	NULL
co-transfected	NULL
construct	NULL
)	NULL
is	NULL
dependent	NULL
on	NULL
several	NULL
factors	NULL
other	NULL
than	NULL
efficiency	NULL
of	NULL
transfection	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
an	NULL
unreliable	NULL
method	NULL
for	NULL
normalization	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
our	NULL
experience	NULL
that	NULL
spectrophotometry	NULL
has	NULL
not	NULL
quantitated	NULL
plasmid	NULL
DNA	NULL
as	NULL
precisely	NULL
as	NULL
expected	NULL
and	NULL
that	NULL
the	NULL
efficiency	NULL
of	NULL
transfection	NULL
is	NULL
critically	NULL
dependent	NULL
on	NULL
the	NULL
purity	NULL
of	NULL
the	NULL
transfected	NULL
plasmid	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
perform	NULL
replicate	NULL
experiments	NULL
using	NULL
independently	NULL
isolated	NULL
and	NULL
purified	NULL
plasmids	NULL
.	NULL

All	NULL
luciferase	NULL
constructs	NULL
in	NULL
a	NULL
particular	NULL
experiment	NULL
are	NULL
:	NULL
(	NULL
a	NULL
)	NULL
derived	NULL
from	NULL
the	NULL
same	NULL
root	NULL
plasmid	NULL
,	NULL
(	NULL
5	NULL
)	NULL
differ	NULL
only	NULL
by	NULL
a	NULL
small	NULL
number	NULL
of	NULL
nucleotides	NULL
,	NULL
(	NULL
c	NULL
)	NULL
are	NULL
twice	NULL
purified	NULL
over	NULL
cesium	NULL
chloride	NULL
,	NULL
and	NULL
(	NULL
d	NULL
)	NULL
quantitated	NULL
by	NULL
both	NULL
spectrophotometry	NULL
and	NULL
on	NULL
agarose	NULL
gel	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
methods	NULL
proposed	NULL
by	NULL
others	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Using	NULL
this	NULL
proce-dure	NULL
,	NULL
replicate	NULL
transfections	NULL
using	NULL
independent	NULL
isolates	NULL
of	NULL
the	NULL
same	NULL
luciferase	NULL
construct	NULL
have	NULL
yielded	NULL
differences	NULL
in	NULL
luciferase	NULL
activity	NULL
of	NULL
<	NULL
10	NULL
%	NULL
.	NULL

This	NULL
is	NULL
more	NULL
consistent	NULL
,	NULL
and	NULL
accurate	NULL
,	NULL
than	NULL
normalizing	NULL
data	NULL
to	NULL
the	NULL
independently	NULL
variable	NULL
activity	NULL
of	NULL
a	NULL
co-transfected	NULL
second	NULL
construct	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
relative	NULL
light	NULL
units	NULL
(	NULL
RLU	NULL
)	NULL
(	NULL
Mono-light	NULL
Luminometer	NULL
model	NULL
2010	NULL
)	NULL
.	NULL

All	NULL
data	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
mean	NULL
relative	NULL
luciferase	NULL
activity	NULL
as	NULL
calculated	NULL
by	NULL
the	NULL
formula	NULL
(	NULL
RLUt=*	NULL
«	NULL
onstruct/	NULL
RL	NULL
[	NULL
reference	NULL
construct	NULL
)	NULL
¥iror	NULL
Bars	NULL
indicate	NULL
1	NULL
standard	NULL
deviation	NULL
of	NULL
the	NULL
mean	NULL
relative	NULL
luciferase	NULL
activity	NULL
.	NULL

Eectrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay-Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
either	NULL
Jurkat	NULL
T	NULL
cells	NULL
or	NULL
NIH3T3	NULL
cells	NULL
using	NULL
the	NULL
Andrews	NULL
procedure	NULL
and	NULL
were	NULL
used	NULL
in	NULL
gel	NULL
shift	NULL
assays	NULL
as	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Labeling	NULL
of	NULL
the	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
accomplished	NULL
either	NULL
by	NULL
filling	NULL
the	NULL
5°	NULL
ends	NULL
using	NULL
DNA	NULL
polymerase	NULL
large	NULL
fragment	NULL
(	NULL
Klenow	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
dATP	NULL
,	NULL
dGTP	NULL
,	NULL
dTTP	NULL
,	NULL
and	NULL
[	NULL
«	NULL
-*	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
(	NULL
>	NULL
3,000	NULL
Ci/mmol	NULL
;	NULL
DuPont	NULL
NEN	NULL
)	NULL
or	NULL
by	NULL
phosphorylation	NULL
of	NULL
the	NULL
oligonucleotide	NULL
probe	NULL
at	NULL
the	NULL
free	NULL
5'-hy-droxyl	NULL
group	NULL
using	NULL
polynucleotide	NULL
kinase	NULL
and	NULL
[	NULL
y-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
JATP	NULL
(	NULL
>	NULL
3,000	NULL
Ci/	NULL
mmol	NULL
;	NULL
DuPont	NULL
NEN	NULL
)	NULL
.	NULL

Labeled	NULL
probes	NULL
were	NULL
purified	NULL
by	NULL
gel	NULL
electrophore-sis	NULL
.	NULL

A	NULL
50-100	NULL
molar	NULL
excess	NULL
of	NULL
competitor	NULL
oligonucleotides	NULL
were	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
15-20	NULL
min	NULL
prior	NULL
to	NULL
the	NULL
probe	NULL
.	NULL

The	NULL
AP-l-specific	NULL
oligonucleotide	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
N.	NULL
C.	NULL
Andrews	NULL
.	NULL

Antiserum	NULL
specific	NULL
for	NULL
NFATp	NULL
and	NULL
Oct-1	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
A.	NULL
Rao	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
respectively	NULL
.	NULL

RESULTS	NULL
The	NULL
CBF	NULL
Site	NULL
within	NULL
the	NULL
Human	NULL
IL-3	NULL
Promoter	NULL
Is	NULL
Position	NULL
sensitive-We	NULL
previously	NULL
demonstrated	NULL
that	NULL
CBF	NULL
is	NULL
necessary	NULL
for	NULL
IL-3	NULL
promoter	NULL
activity	NULL
(	NULL
3	NULL
)	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
CBF	NULL
,	NULL
a	NULL
new	NULL
site	NULL
(	NULL
CBF*	NULL
)	NULL
was	NULL
introduced	NULL
51	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
endogenous	NULL
location	NULL
and	NULL
tested	NULL
for	NULL
its	NULL
capacity	NULL
to	NULL
rescue	NULL
the	NULL
activity	NULL
of	NULL
an	NULL
IL-3	NULL
promoter	NULL
mutated	NULL
at	NULL
the	NULL
resident	NULL
CBF	NULL
site	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
human	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
JKE6.1	NULL
.	NULL

As	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
there	NULL
is	NULL
little	NULL
promoter	NULL
activity	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
2	NULL
D.	NULL
S.	NULL
Taylor	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
14022	NULL
§§	NULL
unstimulated	NULL
[	NULL
]	NULL
Stimulated	NULL
JKE8.1	NULL
Ctl	NULL
-315pL	NULL
-315/GCpL	NULL
-315°CBFpL	NULL
-315°CBF/GCpL	NULL
0	NULL
0.2	NULL
0.4	NULL
0.6	NULL
0.8	NULL
1	NULL
1.2	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
191	NULL
183	NULL
|	NULL
ACT-1	NULL
_	NULL
CBF	NULL
|	NULL
6	NULL
-315pL	NULL
-315/GCpL	NULL
-315°CBFpL	NULL
~315	NULL
``	NULL
CBF/GCpL	NULL
Probe	NULL
CBF	NULL
*CBF	NULL
oa	NULL
--	NULL
--	NULL
-	NULL
___	NULL
,	NULL
#	NULL
%	NULL
Bo	NULL
Jo	NULL
€	NULL
m	NULL
ou	NULL
&	NULL
Competitor	NULL
5	NULL
gop	NULL
&	NULL
$	NULL
3	NULL
S	NULL
&	NULL
=	NULL
yolk	NULL
|	NULL
war	NULL
w	NULL
Jurkat	NULL
E6.1	NULL
CBF	NULL
GATCACGTCTGTGGTTTTCATG	NULL
*CBF	NULL
TCTTTTTTGTGGTTTCACTG	NULL
--	NULL
-	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

*CBF	NULL
only	NULL
partially	NULL
overcomes	NULL
CBF	NULL
(	NULL
G-C	NULL
)	NULL
mutation	NULL
.	NULL

A	NULL
,	NULL
Jurkat	NULL
T-cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
individual	NULL
promoter	NULL
constructs	NULL
depicted	NULL
schematically	NULL
in	NULL
the	NULL
lower	NULL
portion	NULL
of	NULL
the	NULL
panel	NULL
.	NULL

Single	NULL
base	NULL
mutations	NULL
were	NULL
introduced	NULL
to	NULL
create	NULL
the	NULL
*CBF	NULL
site	NULL
and	NULL
are	NULL
indicated	NULL
in	NULL
boldface	NULL
type	NULL
.	NULL

Sixteen	NULL
hours	NULL
after	NULL
transfection	NULL
cells	NULL
were	NULL
mock-stimulated	NULL
or	NULL
stimulated	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
TPA	NULL
and	NULL
ionomycin	NULL
.	NULL

Six	NULL
hours	NULL
after	NULL
stimulation	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
cell	NULL
lysates	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
RLU	NULL
.	NULL

The	NULL
data	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
mean	NULL
relative	NULL
luciferase	NULL
activity	NULL
as	NULL
calculated	NULL
by	NULL
the	NULL
formula	NULL
construct/pT	NULL
[	NULL
reference	NULL
construct	NULL
)	NULL
,	NULL
,	NULL
,	NULL
.	NULL

bars	NULL
indicate	NULL
1	NULL
standard	NULL
deviation	NULL
of	NULL
the	NULL
mean	NULL
relative	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
stimulated	NULL
wild	NULL
type	NULL
IL-3	NULL
promoter	NULL
(	NULL
-315pL	NULL
)	NULL
is	NULL
the	NULL
reference	NULL
construct	NULL
in	NULL
this	NULL
experiment	NULL
and	NULL
has	NULL
a	NULL
relative	NULL
luciferase	NULL
activity	NULL
of	NULL
1.0	NULL
.	NULL

B	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
competitor	NULL
oligonucleotide	NULL
and	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
corresponding	NULL
to	NULL
either	NULL
the	NULL
endogenous	NULL
CBF	NULL
site	NULL
or	NULL
the	NULL
newly	NULL
introduced	NULL
CBF	NULL
site	NULL
(	NULL
*CBF	NULL
)	NULL
.	NULL

The	NULL
CBF	NULL
binding	NULL
site	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
bracket	NULL
.	NULL

Functional	NULL
Role	NULL
of	NULL
CBF	NULL
in	NULL
the	NULL
Regulation	NULL
of	NULL
Interleukin-3	NULL
(	NULL
-315pL	NULL
)	NULL
.	NULL

Upon	NULL
stimulation	NULL
with	NULL
TPA	NULL
and	NULL
ionomycin	NULL
,	NULL
there	NULL
is	NULL
up-regulation	NULL
of	NULL
promoter	NULL
activity	NULL
,	NULL
which	NULL
is	NULL
significantly	NULL
reduced	NULL
by	NULL
a	NULL
G-C	NULL
mutation	NULL
of	NULL
the	NULL
endogenous	NULL
CBF	NULL
binding	NULL
site	NULL
(	NULL
-315/GCpL	NULL
)	NULL
.	NULL

Introduction	NULL
of	NULL
a	NULL
second	NULL
CBF	NULL
site	NULL
(	NULL
-315*CBFpL	NULL
)	NULL
neither	NULL
increased	NULL
the	NULL
base-line	NULL
promoter	NULL
activity	NULL
nor	NULL
completely	NULL
rescued	NULL
activity	NULL
of	NULL
the	NULL
CBF/GC	NULL
mutant	NULL
promoter	NULL
(	NULL
-315*CBF/GCpL	NULL
)	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
the	NULL
created	NULL
*CBF	NULL
site	NULL
bound	NULL
the	NULL
CBF	NULL
complex	NULL
,	NULL
gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

Both	NULL
the	NULL
CBF	NULL
and	NULL
the	NULL
*CBF	NULL
sites	NULL
bind	NULL
a	NULL
protein	NULL
complex	NULL
with	NULL
a	NULL
similar	NULL
mobility	NULL
and	NULL
cross-compete	NULL
with	NULL
one	NULL
another	NULL
for	NULL
binding	NULL
to	NULL
that	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Equivalent	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
nuclear	NULL
extract	NULL
from	NULL
both	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
*CBF	NULL
site	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
the	NULL
CBF	NULL
protein	NULL
complex	NULL
,	NULL
but	NULL
does	NULL
not	NULL
alter	NULL
promoter	NULL
activity	NULL
,	NULL
the	NULL
location	NULL
of	NULL
the	NULL
CBF	NULL
site	NULL
in	NULL
the	NULL
IL-3	NULL
promoter	NULL
appears	NULL
critical	NULL
for	NULL
its	NULL
biologic	NULL
activity	NULL
.	NULL

The	NULL
Act-1	NULL
and	NULL
CBF	NULL
Sites	NULL
Form	NULL
a	NULL
Functional	NULL
Unit-The	NULL
endogenous	NULL
CBF	NULL
site	NULL
within	NULL
the	NULL
IL-3	NULL
promoter	NULL
is	NULL
interesting	NULL
as	NULL
it	NULL
is	NULL
juxtaposed	NULL
to	NULL
another	NULL
important	NULL
regulatory	NULL
element	NULL
,	NULL
Act-1	NULL
.	NULL

Such	NULL
juxtaposition	NULL
of	NULL
CBF	NULL
and	NULL
another	NULL
regulatory	NULL
site	NULL
is	NULL
a	NULL
recurring	NULL
motif	NULL
in	NULL
other	NULL
promoter/enhancer	NULL
elements	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
,	NULL
and	NULL
suggests	NULL
a	NULL
functional	NULL
interdependence	NULL
between	NULL
the	NULL
CBF	NULL
and	NULL
Act-1	NULL
sites	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
functional	NULL
interdependence	NULL
of	NULL
the	NULL
Act-1	NULL
and	NULL
CBF	NULL
sites	NULL
,	NULL
a	NULL
second	NULL
Act-1/CBF	NULL
(	NULL
AC	NULL
)	NULL
unit	NULL
,	NULL
or	NULL
a	NULL
mutant	NULL
thereof	NULL
,	NULL
was	NULL
introduced	NULL
upstream	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
site	NULL
at	NULL
nt	NULL
-180	NULL
.	NULL

Introduction	NULL
of	NULL
either	NULL
the	NULL
wild	NULL
type	NULL
,	NULL
or	NULL
one	NULL
of	NULL
several	NULL
mutants	NULL
of	NULL
the	NULL
AC	NULL
unit	NULL
,	NULL
did	NULL
not	NULL
involve	NULL
the	NULL
deletion	NULL
of	NULL
endogenous	NULL
nucleotides	NULL
and	NULL
resulted	NULL
in	NULL
extension	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
by	NULL
34-42	NULL
bp	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
our	NULL
previous	NULL
experiments	NULL
with	NULL
promoters	NULL
containing	NULL
the	NULL
*CBF	NULL
site	NULL
(	NULL
-315*CBFpL	NULL
)	NULL
,	NULL
the	NULL
AC	NULL
unit	NULL
significantly	NULL
up-regulates	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
upon	NULL
stimulation	NULL
with	NULL
TPA	NULL
and	NULL
ionomycin	NULL
.	NULL

Insertion	NULL
of	NULL
this	NULL
unit	NULL
also	NULL
resulted	NULL
in	NULL
a	NULL
tendency	NULL
to	NULL
increase	NULL
the	NULL
basal	NULL
(	NULL
constitutive/unstimulated	NULL
)	NULL
activity	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
inserted	NULL
AC	NULL
unit	NULL
overcomes	NULL
the	NULL
inhibition	NULL
of	NULL
promoter	NULL
activity	NULL
caused	NULL
by	NULL
a	NULL
G-C	NULL
mutation	NULL
of	NULL
the	NULL
endogenous	NULL
CBF	NULL
site	NULL
.	NULL

Mutation	NULL
of	NULL
either	NULL
the	NULL
Act-1	NULL
or	NULL
CBF	NULL
component	NULL
of	NULL
the	NULL
AC	NULL
unit	NULL
resulted	NULL
in	NULL
a	NULL
sharp	NULL
decrease	NULL
in	NULL
promoter	NULL
activity	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
the	NULL
Act-1	NULL
and	NULL
CBF	NULL
sites	NULL
function	NULL
only	NULL
as	NULL
a	NULL
unit	NULL
(	NULL
not	NULL
individually	NULL
)	NULL
to	NULL
provide	NULL
inducible	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
AC	NULL
Unit	NULL
Is	NULL
Functional	NULL
in	NULL
a	NULL
Minimal	NULL
Promoter-Having	NULL
established	NULL
the	NULL
functional	NULL
interdependence	NULL
of	NULL
the	NULL
Act-1	NULL
and	NULL
CBF	NULL
sites	NULL
,	NULL
we	NULL
next	NULL
evaluated	NULL
its	NULL
function	NULL
outside	NULL
the	NULL
context	NULL
of	NULL
an	NULL
intact	NULL
,	NULL
full-length	NULL
proximal	NULL
IL-3	NULL
promoter	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
a	NULL
normal	NULL
AC	NULL
unit	NULL
or	NULL
an	NULL
AC	NULL
unit	NULL
containing	NULL
a	NULL
mutant	NULL
CBF	NULL
site	NULL
was	NULL
inserted	NULL
31	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
in	NULL
the	NULL
-61-bp	NULL
minimal	NULL
IL-3	NULL
promoter	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
the	NULL
minimal	NULL
promoter	NULL
has	NULL
significant	NULL
activity	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
compared	NULL
with	NULL
the	NULL
full-length	NULL
-315-bp	NULL
proximal	NULL
IL-3	NULL
promoter	NULL
.	NULL

This	NULL
activity	NULL
is	NULL
further	NULL
augmented	NULL
by	NULL
stimulation	NULL
with	NULL
TPA	NULL
and	NULL
ionomycin	NULL
,	NULL
and	NULL
addition	NULL
of	NULL
a	NULL
complete	NULL
AC	NULL
unit	NULL
increases	NULL
both	NULL
basal	NULL
and	NULL
stimulated	NULL
activity	NULL
of	NULL
the	NULL
minimal	NULL
promoter	NULL
.	NULL

The	NULL
enhancement	NULL
in	NULL
activity	NULL
was	NULL
abrogated	NULL
upon	NULL
introduction	NULL
of	NULL
a	NULL
G-C	NULL
mutation	NULL
to	NULL
the	NULL
CBF	NULL
site	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
AC	NULL
unit	NULL
is	NULL
functional	NULL
both	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
upstream	NULL
elements	NULL
within	NULL
the	NULL
IL-3	NULL
promoter	NULL
and	NULL
within	NULL
31	NULL
bp	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

An	NULL
AC	NULL
Unit	NULL
Is	NULL
Functional	NULL
in	NULL
Heterologous	NULL
Cells-The	NULL
activity	NULL
of	NULL
the	NULL
full-length	NULL
,	NULL
-315-bp	NULL
proximal	NULL
IL-3	NULL
promoter	NULL
is	NULL
highly	NULL
tissue	NULL
restricted	NULL
.	NULL

It	NULL
is	NULL
functional	NULL
only	NULL
in	NULL
human	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Such	NULL
observed	NULL
tissue-specific	NULL
activity	NULL
may	NULL
result	NULL
from	NULL
specific	NULL
positive	NULL
regulation	NULL
in	NULL
a	NULL
permissive	NULL
cell	NULL
type	NULL
,	NULL
specific	NULL
inhibition	NULL
in	NULL
nonpermissive	NULL
cells	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
thereof	NULL
.	NULL

Previous	NULL
work	NULL
in	NULL
this	NULL
laboratory	NULL
identified	NULL
a	NULL
T	NULL
cell-specific	NULL
complex	NULL
that	NULL
,	NULL
upon	NULL
activation	NULL
,	NULL
binds	NULL
the	NULL
5	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
Act-1	NULL
region	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
AC	NULL
unit	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
observed	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Functional	NULL
Role	NULL
of	NULL
CBF	NULL
in	NULL
the	NULL
Regulation	NULL
of	NULL
Interleukin-3	NULL
14023	NULL
TaBL®	NULL
II	NULL
CBF	NULL
adjoins	NULL
other	NULL
regulatory	NULL
sequences	NULL
CBF	NULL
binding	NULL
sites	NULL
are	NULL
indicated	NULL
in	NULL
bold	NULL
type	NULL
.	NULL

Binding	NULL
sites	NULL
of	NULL
other	NULL
regulatory	NULL
elements	NULL
are	NULL
underscored	NULL
(	NULL
8	NULL
,	NULL
11	NULL
,	NULL
34-36	NULL
)	NULL
.	NULL

Promoter	NULL
Sequence	NULL
Regulatory	NULL
element	NULL
IL-3	NULL
ATGAATAATTACGTCTGTGGTTT	NULL
Act1-CBF	NULL
TcR-B	NULL
(	NULL
B	NULL
E2	NULL
)	NULL
CAGGATGTGGTTT	NULL
Ets-CBF	NULL
TcR-B	NULL
CATGTGGTTT	NULL
EBox-CBF	NULL
MoMLV	NULL
CAGGATATCTGTGGTAA	NULL
LVb-CBF	NULL
GM-CSF	NULL
TGTGGTCACCATTAATCATTTCCTCT	NULL
CBF-Cleo	NULL
(	NULL
AP/Ets	NULL
)	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Act-1	NULL
and	NULL
CBF	NULL
form	NULL
a	NULL
functional	NULL
unit	NULL
and	NULL
overcomes	NULL
a	NULL
CBF	NULL
(	NULL
G-C	NULL
)	NULL
mutation	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
individual	NULL
promoter	NULL
constructs	NULL
depicted	NULL
schematically	NULL
on	NULL
the	NULL
left	NULL
portion	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

16	NULL
h	NULL
after	NULL
transfection	NULL
cells	NULL
were	NULL
mock-stimulated	NULL
or	NULL
stimulated	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
TPA	NULL
and	NULL
ionomycin	NULL
.	NULL

6	NULL
h	NULL
after	NULL
stimulation	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
cell	NULL
lysates	NULL
.	NULL

Data	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
presented	NULL
as	NULL
outlined	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
stimulated	NULL
wild	NULL
type	NULL
IL-3	NULL
promoter	NULL
(	NULL
top	NULL
construct	NULL
)	NULL
is	NULL
the	NULL
reference	NULL
construct	NULL
in	NULL
this	NULL
experiment	NULL
and	NULL
has	NULL
a	NULL
relative	NULL
luciferase	NULL
activity	NULL
of	NULL
1.0.	NULL
ea	NULL
Vera	NULL
selective	NULL
activity	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
minimal	NULL
IL-3	NULL
promoter	NULL
with	NULL
,	NULL
and	NULL
without	NULL
,	NULL
a	NULL
functional	NULL
AC	NULL
unit	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
full-length	NULL
-315-bp	NULL
IL-3	NULL
promoter	NULL
in	NULL
heterologous	NULL
,	NULL
murine	NULL
NIH3T3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
full-length	NULL
IL-3	NULL
promoter	NULL
,	NULL
the	NULL
minimal	NULL
IL-3	NULL
promoter	NULL
has	NULL
significant	NULL
activity	NULL
in	NULL
unstimulated	NULL
NIH3T3	NULL
cells	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
minimal	NULL
promoter	NULL
in	NULL
these	NULL
fibroblasts	NULL
is	NULL
enhanced	NULL
approximately	NULL
2-fold	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
single	NULL
AC	NULL
unit	NULL
.	NULL

The	NULL
AC	NULL
unit	NULL
increases	NULL
basal	NULL
(	NULL
unstimulated	NULL
)	NULL
promoter	NULL
activity	NULL
when	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
(	NULL
-61	NULL
bp	NULL
)	NULL
IL-3	NULL
promoter	NULL
in	NULL
both	NULL
Jurkat	NULL
T-cells	NULL
and	NULL
NIH3T3	NULL
fibroblasts	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
AC	NULL
unit	NULL
increases	NULL
the	NULL
stimulation	NULL
index	NULL
(	NULL
stimu-lated	NULL
/unstimulated	NULL
)	NULL
in	NULL
the	NULL
context	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
but	NULL
not	NULL
NIH3T3	NULL
fibroblasts	NULL
.	NULL

By	NULL
virtue	NULL
of	NULL
its	NULL
inducible	NULL
positive	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
AC	NULL
unit	NULL
contributes	NULL
to	NULL
the	NULL
tissue-specific	NULL
regulation	NULL
of	NULL
IL-3	NULL
gene	NULL
expression	NULL
.	NULL

Both	NULL
the	NULL
Act-1	NULL
and	NULL
CBF	NULL
segments	NULL
of	NULL
the	NULL
AC	NULL
unit	NULL
bind	NULL
protein	NULL
complexes	NULL
common	NULL
to	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
Jurkat	NULL
and	NULL
NIH3T3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
CBF	NULL
segment	NULL
of	NULL
the	NULL
AC	NULL
unit	NULL
binds	NULL
a	NULL
major	NULL
complex	NULL
in	NULL
NIH3T3	NULL
cells	NULL
that	NULL
migrates	NULL
and	NULL
competes	NULL
identically	NULL
to	NULL
the	NULL
previously	NULL
identified	NULL
CBF	NULL
protein	NULL
complex	NULL
present	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

The	NULL
more	NULL
diffuse	NULL
appearance	NULL
of	NULL
this	NULL
complex	NULL
in	NULL
NIHS3T3	NULL
cells	NULL
may	NULL
result	NULL
from	NULL
more	NULL
than	NULL
one	NULL
closely	NULL
migrating	NULL
complex	NULL
and	NULL
suggests	NULL
the	NULL
presence	NULL
of	NULL
more	NULL
than	NULL
a	NULL
single	NULL
isoform	NULL
of	NULL
CBF	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

The	NULL
Act-1	NULL
region	NULL
of	NULL
the	NULL
AC	NULL
unit	NULL
binds	NULL
to	NULL
a	NULL
slowly	NULL
migrating	NULL
complex	NULL
present	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

This	NULL
band	NULL
was	NULL
previously	NULL
identified	NULL
in	NULL
this	NULL
laboratory	NULL
as	NULL
Oct-1	NULL
or	NULL
an	NULL
Oct-1-like	NULL
protein	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
faster	NULL
migrating	NULL
complex	NULL
that	NULL
is	NULL
specifically	NULL
competed	NULL
by	NULL
Act-1	NULL
in	NULL
the	NULL
Jurkat	NULL
nuclear	NULL
extract	NULL
represents	NULL
the	NULL
recently	NULL
identified	NULL
E4BP4	NULL
protein	NULL
,	NULL
NFIL3A	NULL
(	NULL
25	NULL
)	NULL
.	NULL

A	NULL
Positive	NULL
Regulatory	NULL
Element	NULL
(	NULL
CK3	NULL
)	NULL
Is	NULL
Present	NULL
between	NULL
nt	NULL
-180	NULL
and	NULL
nt	NULL
-207	NULL
of	NULL
the	NULL
IL-3	NULL
Promoter-Insertion	NULL
of	NULL
the	NULL
AC	NULL
unit	NULL
into	NULL
the	NULL
full-length	NULL
proximal	NULL
IL-3	NULL
promoter	NULL
resulted	NULL
both	NULL
in	NULL
elongation	NULL
of	NULL
the	NULL
promoter	NULL
and	NULL
a	NULL
tendency	NULL
to	NULL
increase	NULL
basal	NULL
(	NULL
unstimulated	NULL
)	NULL
promoter	NULL
as	NULL
noted	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

As	NULL
the	NULL
NIP	NULL
repressor	NULL
element	NULL
maps	NULL
to	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
,	NULL
AP10Elflip	NULL
Act1	NULL
CBF	NULL
PO	NULL
(	NULL
EH-CLucif	NULL
)	NULL
§o*-	NULL
{	NULL
#	NULL
#	NULL
+	NULL
--	NULL
eap-	NULL
JKE6.1	NULL
§	NULL
Unstimulated	NULL
[	NULL
77	NULL
]	NULL
Stimulated	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
it	NULL
was	NULL
possible	NULL
that	NULL
the	NULL
inserted	NULL
nucleotides	NULL
diminished	NULL
its	NULL
effect	NULL
by	NULL
increasing	NULL
the	NULL
distance	NULL
between	NULL
NIP	NULL
and	NULL
other	NULL
important	NULL
downstream	NULL
elements	NULL
.	NULL

To	NULL
investigate	NULL
this	NULL
possibility	NULL
,	NULL
the	NULL
promoter	NULL
fragment	NULL
between	NULL
nt	NULL
-180	NULL
and	NULL
nt	NULL
-207	NULL
was	NULL
deleted	NULL
and	NULL
replaced	NULL
with	NULL
an	NULL
AC	NULL
unit	NULL
.	NULL

This	NULL
region	NULL
was	NULL
chosen	NULL
as	NULL
it	NULL
contained	NULL
no	NULL
previously	NULL
identified	NULL
promoter	NULL
elements	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
constancy	NULL
of	NULL
the	NULL
distance	NULL
between	NULL
NIP	NULL
and	NULL
other	NULL
downstream	NULL
elements	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
restores	NULL
a	NULL
low	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
additional	NULL
AC	NULL
unit	NULL
.	NULL

Furthermore	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
endogenous	NULL
CBF	NULL
is	NULL
fully	NULL
rescued	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
upstream	NULL
AC	NULL
unit	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
region	NULL
between	NULL
nt	NULL
-180	NULL
and	NULL
nt	NULL
-207	NULL
causes	NULL
a	NULL
decrease	NULL
in	NULL
overall	NULL
promoter	NULL
activity	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
previously	NULL
unidentified	NULL
positive	NULL
regulatory	NULL
element	NULL
is	NULL
perturbed	NULL
in	NULL
this	NULL
promoter	NULL
construct	NULL
.	NULL

To	NULL
further	NULL
analyze	NULL
this	NULL
region	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
-180-bp	NULL
IL-3	NULL
promoter	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
-207	NULL
and	NULL
-315	NULL
IL-3	NULL
promoter	NULL
constructs	NULL
in	NULL
both	NULL
Jurkat	NULL
and	NULL
NIH3T3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
all	NULL
experiments	NULL
performed	NULL
,	NULL
regardless	NULL
of	NULL
cell	NULL
type	NULL
,	NULL
inclusion	NULL
of	NULL
the	NULL
27	NULL
bp	NULL
between	NULL
nt	NULL
-180	NULL
and	NULL
nt	NULL
-207	NULL
induced	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
promoter	NULL
activity	NULL
.	NULL

Two	NULL
Specific	NULL
Complexes	NULL
Are	NULL
Bound	NULL
by	NULL
the	NULL
CK3	NULL
Element-The	NULL
coding	NULL
strand	NULL
of	NULL
DNA	NULL
between	NULL
nt	NULL
-180	NULL
and	NULL
nt	NULL
-207	NULL
bears	NULL
no	NULL
homology	NULL
to	NULL
known	NULL
regulatory	NULL
elements	NULL
.	NULL

However	NULL
,	NULL
the	NULL
noncoding	NULL
strand	NULL
contains	NULL
sequences	NULL
that	NULL
are	NULL
similar	NULL
,	NULL
but	NULL
not	NULL
identi-cal	NULL
,	NULL
to	NULL
known	NULL
binding	NULL
sites	NULL
for	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
the	NULL
3	NULL
'	NULL
portion	NULL
of	NULL
Act-1	NULL
(	NULL
Table	NULL
III	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
IL-3	NULL
promoter	NULL
in	NULL
this	NULL
region	NULL
(	NULL
CK3	NULL
)	NULL
,	NULL
gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
as	NULL
a	NULL
probe	NULL
both	NULL
a	NULL
restriction	NULL
fragment	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
containing	NULL
these	NULL
nucleotides	NULL
(	NULL
Msel-Sausa	NULL
)	NULL
and	NULL
a	NULL
synthetic	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
nucleotides	NULL
of	NULL
interest	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Both	NULL
probes	NULL
bind	NULL
a	NULL
faster	NULL
migrating	NULL
complex	NULL
(	NULL
CK3a	NULL
)	NULL
and	NULL
a	NULL
slower	NULL
migrating	NULL
doublet	NULL
(	NULL
CK3b	NULL
)	NULL
.	NULL

The	NULL
faster	NULL
migrating	NULL
protein	NULL
complex	NULL
(	NULL
CK3a	NULL
)	NULL
is	NULL
specifically	NULL
competed	NULL
by	NULL
unlabeled	NULL
``	NULL
self	NULL
``	NULL
oligonucleotide	NULL
and	NULL
nucleotides	NULL
containing	NULL
the	NULL
complete	NULL
Act-1	NULL
site	NULL
,	NULL
but	NULL
is	NULL
not	NULL
competed	NULL
by	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
only	NULL
the	NULL
5	NULL
portion	NULL
of	NULL
the	NULL
Act-1	NULL
site	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
14024	NULL
A	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

The	NULL
Act-1/CBF	NULL
unit	NULL
enhances	NULL
transcription	NULL
activity	NULL
of	NULL
a	NULL
minimal	NULL
promoter	NULL
in	NULL
both	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
NIH3T3	NULL
fibroblasts	NULL
.	NULL

A	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
promoter	NULL
constructs	NULL
and	NULL
stimulated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

An	NULL
AC	NULL
unit	NULL
containing	NULL
either	NULL
a	NULL
wild	NULL
type	NULL
or	NULL
mutant	NULL
CBF	NULL
binding	NULL
site	NULL
was	NULL
appended	NULL
to	NULL
the	NULL
5	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
minimal	NULL
(	NULL
-61	NULL
bp	NULL
)	NULL
IL-3	NULL
promoter	NULL
as	NULL
outlined	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
and	NULL
compared	NULL
with	NULL
the	NULL
minimal	NULL
IL-3	NULL
promoter	NULL
.	NULL

Data	NULL
Elfi	NULL
from	NULL
five	NULL
independent	NULL
experiments	NULL
are	NULL
API	NULL
&	NULL
_	NULL
NI	NULL
presented	NULL
as	NULL
outlined	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
stim-	NULL
o	NULL
ulated	NULL
minimal	NULL
(	NULL
-61	NULL
bp	NULL
)	NULL
promoter	NULL
(	NULL
sec-	NULL
ond	NULL
construct	NULL
)	NULL
is	NULL
the	NULL
reference	NULL
construct	NULL
in	NULL
this	NULL
experiment	NULL
and	NULL
has	NULL
a	NULL
relative	NULL
lu	NULL
ciferase	NULL
activity	NULL
of	NULL
1.0	NULL
.	NULL

In	NULL
one	NULL
of	NULL
five	NULL
ex	NULL
periments	NULL
the	NULL
full-length	NULL
(	NULL
-815	NULL
bp	NULL
)	NULL
prox-	NULL
imal	NULL
IL-3	NULL
promoter	NULL
(	NULL
bottom	NULL
construct	NULL
)	NULL
was	NULL
included	NULL
for	NULL
the	NULL
purpose	NULL
of	NULL
comparison	NULL
.	NULL

B	NULL
,	NULL
B	NULL
murine	NULL
NIHS3T3	NULL
fibroblast	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
promoter	NULL
constructs	NULL
using	NULL
the	NULL
calcium	NULL
phosphate	NULL
method	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
for	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
then	NULL
stimulated	NULL
for	NULL
7	NULL
h	NULL
with	NULL
TPA	NULL
only	NULL
as	NULL
stimulation	NULL
of	NULL
NIHST3	NULL
cells	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
TPA	NULL
and	NULL
ionomycin	NULL
substantially	NULL
decrease	NULL
activity	NULL
of	NULL
all	NULL
pro	NULL
moter	NULL
constructs	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
iso-	NULL
lated	NULL
and	NULL
assessed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

Data	NULL
from	NULL
four	NULL
independent	NULL
experiments	NULL
are	NULL
presented	NULL
as	NULL
outlined	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
stimulated	NULL
minimal	NULL
(	NULL
-61	NULL
bp	NULL
)	NULL
promoter	NULL
(	NULL
second	NULL
construct	NULL
)	NULL
is	NULL
the	NULL
reference	NULL
con	NULL
struct	NULL
in	NULL
this	NULL
experiment	NULL
and	NULL
has	NULL
a	NULL
rela-	NULL
AP1	NULL
Ef	NULL
}	NULL
tive	NULL
luciferase	NULL
activity	NULL
of	NULL
1.0	NULL
.	NULL

The	NULL
-173	NULL
bp	NULL
IL-3	NULL
promoter	NULL
construct	NULL
was	NULL
present	NULL
in	NULL
one	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

P	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Oct-1	NULL
is	NULL
known	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
3	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
Act-1	NULL
site	NULL
,	NULL
but	NULL
antiserum	NULL
specific	NULL
for	NULL
Oct-1	NULL
does	NULL
not	NULL
supershift	NULL
CKS8a	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
despite	NULL
similarity	NULL
to	NULL
an	NULL
AP-1	NULL
site	NULL
,	NULL
the	NULL
CK3a	NULL
complex	NULL
migrates	NULL
much	NULL
more	NULL
rapidly	NULL
than	NULL
the	NULL
AP-1	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
and	NULL
the	NULL
same	NULL
AP-1-specific	NULL
oligonucleotide	NULL
does	NULL
not	NULL
compete	NULL
for	NULL
CK3a	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Protein	NULL
binding	NULL
associated	NULL
with	NULL
the	NULL
slower	NULL
migrating	NULL
doublet	NULL
(	NULL
CK3b	NULL
)	NULL
is	NULL
specifically	NULL
inhibited	NULL
by	NULL
unlabeled	NULL
oligonucleotide	NULL
containing	NULL
either	NULL
the	NULL
5	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
NFAT	NULL
region	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
IL2NFAT	NULL
)	NULL
or	NULL
the	NULL
NFAT-like	NULL
sequence	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
(	NULL
ILENFAT	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
antiserum	NULL
specific	NULL
for	NULL
NFATp	NULL
does	NULL
not	NULL
supershift	NULL
the	NULL
CK3b	NULL
complex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
CK3	NULL
region	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
identifies	NULL
proteins	NULL
that	NULL
bind	NULL
DNA	NULL
with	NULL
specificities	NULL
that	NULL
are	NULL
similar	NULL
to	NULL
,	NULL
but	NULL
distinct	NULL
from	NULL
,	NULL
Oct-1	NULL
and	NULL
NFAT	NULL
.	NULL

DISCUSSION	NULL
IL-3	NULL
is	NULL
a	NULL
lymphokine	NULL
important	NULL
for	NULL
normal	NULL
hematopoiesis	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Its	NULL
expression	NULL
is	NULL
highly	NULL
tissue-specific	NULL
,	NULL
being	NULL
expressed	NULL
primarily	NULL
in	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
its	NULL
promoter	NULL
has	NULL
been	NULL
extensively	NULL
studied	NULL
(	NULL
3-6	NULL
)	NULL
.	NULL

Most	NULL
recently	NULL
,	NULL
in	NULL
vivo	NULL
footprinting	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
identified	NULL
a	NULL
CBF	NULL
binding	NULL
site	NULL
as	NULL
one	NULL
of	NULL
the	NULL
few	NULL
regions	NULL
specifically	NULL
protected	NULL
upon	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
initial	NULL
characterization	NULL
of	NULL
this	NULL
site	NULL
indicated	NULL
that	NULL
CBF	NULL
binding	NULL
to	NULL
the	NULL
IL-3	NULL
promoter	NULL
is	NULL
necessary	NULL
,	NULL
but	NULL
not	NULL
sufficient	NULL
,	NULL
for	NULL
IL-3	NULL
promoter	NULL
activity	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
recent	NULL
identification	NULL
of	NULL
mutant	NULL
CBF	NULL
proteins	NULL
created	NULL
by	NULL
the	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
,	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
,	NULL
and	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
chromosomal	NULL
rearrangements	NULL
and	NULL
the	NULL
association	NULL
of	NULL
these	NULL
rearrangements	NULL
with	NULL
specific	NULL
subtypes	NULL
of	NULL
AML	NULL
or	NULL
MDS	NULL
has	NULL
encouraged	NULL
intense	NULL
study	NULL
of	NULL
the	NULL
Act	NULL
!	NULL

CBF	NULL
G18	NULL
CLucif	NULL
)	NULL
Cree	NULL
Ex	NULL
“	NULL
v	NULL
Act1	NULL
CBF	NULL
``	NULL
``	NULL
zerire	NULL
\a\	NULL
Z	NULL
UB	NULL
--	NULL
CTuciP	NULL
)	NULL
Functional	NULL
Role	NULL
of	NULL
CBF	NULL
in	NULL
the	NULL
Regulation	NULL
of	NULL
Interleukin-3	NULL
JKE6.1	NULL
§	NULL
Unstimulated	NULL
[	NULL
]	NULL
]	NULL
Stimulated	NULL
«	NULL
CLucif	NULL
TATA	NULL
0	NULL
05	NULL
1	NULL
150	NULL
2	NULL
250	NULL
3	NULL
35	NULL
4.5005	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
§	NULL
Unstimulated	NULL
[	NULL
T	NULL
]	NULL
Stimulated	NULL
NIH3T3	NULL
«	NULL
Lucif	NULL
»	NULL
-s	NULL
,	NULL
TATA	NULL
OX	NULL
{	NULL
cian	NULL
0	NULL
_	NULL
05	NULL
1	NULL
1.5	NULL
25	NULL
0	NULL
3	NULL
-	NULL
35	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
mutant	NULL
CBF	NULL
fusion	NULL
proteins	NULL
(	NULL
14-16	NULL
,	NULL
26	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
understanding	NULL
of	NULL
normal	NULL
CBF	NULL
function	NULL
remains	NULL
incomplete	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
a	NULL
functional	NULL
CBF	NULL
site	NULL
within	NULL
the	NULL
IL-3	NULL
proximal	NULL
promoter	NULL
provided	NULL
an	NULL
ideal	NULL
context	NULL
in	NULL
which	NULL
to	NULL
more	NULL
closely	NULL
evaluate	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
important	NULL
regulatory	NULL
complex	NULL
.	NULL

The	NULL
present	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
CBF	NULL
complex	NULL
can	NULL
not	NULL
function	NULL
alone	NULL
.	NULL

This	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
a	NULL
second	NULL
CBF	NULL
binding	NULL
site	NULL
(	NULL
*CBF	NULL
)	NULL
that	NULL
binds	NULL
the	NULL
CBF	NULL
complex	NULL
in	NULL
a	NULL
gel	NULL
shift	NULL
assay	NULL
provides	NULL
neither	NULL
positive	NULL
promoter	NULL
activity	NULL
nor	NULL
overcomes	NULL
a	NULL
mutation	NULL
of	NULL
the	NULL
endogenous	NULL
CBF	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
CBF	NULL
site	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
adjacent	NULL
Act-1	NULL
region	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
both	NULL
augments	NULL
promoter	NULL
activity	NULL
and	NULL
overcomes	NULL
a	NULL
null	NULL
mutation	NULL
of	NULL
the	NULL
endogenous	NULL
CBF	NULL
site	NULL
.	NULL

Both	NULL
effects	NULL
are	NULL
abrogated	NULL
by	NULL
mutation	NULL
of	NULL
either	NULL
the	NULL
Act-1	NULL
or	NULL
CBF	NULL
component	NULL
of	NULL
the	NULL
unit	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
AC	NULL
unit	NULL
functions	NULL
similarly	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
minimal	NULL
(	NULL
-61	NULL
bp	NULL
)	NULL
IL-3	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
AC	NULL
unit	NULL
is	NULL
an	NULL
autologous	NULL
functional	NULL
unit	NULL
that	NULL
retains	NULL
its	NULL
activity	NULL
outside	NULL
the	NULL
context	NULL
of	NULL
a	NULL
full-length	NULL
IL-3	NULL
promoter	NULL
and	NULL
requires	NULL
both	NULL
the	NULL
Act-1	NULL
and	NULL
CBF	NULL
sites	NULL
to	NULL
be	NULL
intact	NULL
.	NULL

The	NULL
AC	NULL
unit	NULL
functions	NULL
in	NULL
both	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
Jurkat	NULL
)	NULL
and	NULL
murine	NULL
fibroblasts	NULL
(	NULL
NIH3T3	NULL
)	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
cell	NULL
types	NULL
contain	NULL
proteins	NULL
that	NULL
bind	NULL
similarly	NULL
to	NULL
both	NULL
the	NULL
Act-1	NULL
and	NULL
CBF	NULL
sites	NULL
of	NULL
the	NULL
AC	NULL
unit	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
the	NULL
context	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
AC	NULL
unit	NULL
augments	NULL
both	NULL
basal	NULL
(	NULL
constitutive/unstimulated	NULL
)	NULL
and	NULL
inducible	NULL
(	NULL
stimulated	NULL
)	NULL
promoter	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
the	NULL
augmentation	NULL
of	NULL
inducible	NULL
promoter	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
greater	NULL
than	NULL
the	NULL
augmentation	NULL
of	NULL
basal	NULL
activity	NULL
as	NULL
indicated	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
stimulation	NULL
index	NULL
of	NULL
an	NULL
IL-3	NULL
promoter	NULL
containing	NULL
a	NULL
second	NULL
AC	NULL
unit	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
is	NULL
not	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Functional	NULL
Role	NULL
of	NULL
CBF	NULL
in	NULL
the	NULL
Regulation	NULL
of	NULL
Interleukin-3	NULL
A	NULL
Probe	NULL
CBF	NULL
--	NULL
-	NULL
--	NULL
-	NULL
@	NULL
ow	NULL
Wo	NULL
To	NULL
g	NULL
oa	NULL
e	NULL
Competitor	NULL
5	NULL
o	NULL
8	NULL
%	NULL
55	NULL
8	NULL
t	NULL
P	NULL
2	NULL
&	NULL
2	NULL
4	NULL
2	NULL
8	NULL
?	NULL

4	NULL
BB	NULL
Wag	NULL
vae	NULL
--	NULL
-	NULL
]	NULL
Jurkat	NULL
26.1	NULL
NIH3T3	NULL
CBF	NULL
GATCACGTCTGTGGTTTTCATG	NULL
*CBF	NULL
TCTTTTTTGTGGTTTCACTG	NULL
B	NULL
Probe	NULL
Act-1	NULL
a	NULL
©	NULL
u-Competitor	NULL
5	NULL
a	NULL
&	NULL
§0°	NULL
%	NULL
2	NULL
m	NULL
0	NULL
2	NULL
m	NULL
o	NULL
'ﬁﬂu	NULL
bus	NULL
o	NULL
--	NULL
]	NULL
r	NULL
--	NULL
Jurkat	NULL
26.1	NULL
-	NULL
NIH3T3	NULL
Act-1	NULL
CATGGATGAATAATTACGTCTGCA	NULL
OCT-1	NULL
EA4BP4/NFIL3A	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

The	NULL
Act-1	NULL
and	NULL
CBF	NULL
sites	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
bind	NULL
similar	NULL
protein	NULL
complexes	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
NIHST3	NULL
fibroblasts	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
either	NULL
unstimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
or	NULL
unstimulated	NULL
NIH3T3	NULL
cells	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
competitor	NULL
oligonucleotide	NULL
and	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
corresponding	NULL
to	NULL
either	NULL
the	NULL
endogenous	NULL
CBF	NULL
(	NULL
4	NULL
)	NULL
or	NULL
endogenous	NULL
Act-1	NULL
(	NULL
B	NULL
)	NULL
site	NULL
.	NULL

A	NULL
,	NULL
the	NULL
arrow	NULL
indicates	NULL
the	NULL
CBF	NULL
protein	NULL
complex	NULL
,	NULL
and	NULL
the	NULL
bracket	NULL
indicates	NULL
the	NULL
CBF	NULL
binding	NULL
site	NULL
.	NULL

B	NULL
,	NULL
the	NULL
arrow	NULL
indicates	NULL
the	NULL
Oct-1	NULL
protein	NULL
complex	NULL
.	NULL

The	NULL
boxed	NULL
nucleotides	NULL
of	NULL
the	NULL
Act-1	NULL
probe	NULL
correspond	NULL
to	NULL
the	NULL
previously	NULL
defined	NULL
Act-1	NULL
region	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
.	NULL

Brackets	NULL
indicate	NULL
the	NULL
Oct-1	NULL
and	NULL
E4BP4/NFIL3A	NULL
binding	NULL
sites	NULL
.	NULL

observed	NULL
in	NULL
NIH3T3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
AC	NULL
unit	NULL
contributes	NULL
to	NULL
the	NULL
tissue-specific	NULL
expression	NULL
of	NULL
IL-3	NULL
by	NULL
its	NULL
selective	NULL
positive	NULL
contribution	NULL
to	NULL
inducible	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
context	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
mechanism	NULL
underlying	NULL
the	NULL
interdependence	NULL
of	NULL
the	NULL
Act-1	NULL
and	NULL
CBF	NULL
sites	NULL
is	NULL
unknown	NULL
.	NULL

As	NULL
shown	NULL
for	NULL
other	NULL
DNA	NULL
binding	NULL
14025	NULL
]	NULL
Unstimulated	NULL
[	NULL
_	NULL
]	NULL
Stimulated	NULL
JKE6.1	NULL
Ctl	NULL
-315pL	NULL
«	NULL
315NACpL	NULL
j	NULL
0	NULL
0.2	NULL
0.4	NULL
0.6	NULL
0.8	NULL
1	NULL
1.2	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
+191	NULL
133	NULL
I	NULL
acr	NULL
cBr	NULL
1	NULL
205	NULL
*~	NULL
*TCTToTTT	NULL
--	NULL
-315pL	NULL
I	NULL
--	NULL
NAC	NULL
--	NULL
+	NULL
>	NULL
~-315NACpL	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Replacement	NULL
of	NULL
IL-3	NULL
promoter	NULL
between	NULL
nt	NULL
-180	NULL
and	NULL
nt	NULL
-207	NULL
decreases	NULL
promoter	NULL
activity	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
promoter	NULL
constructs	NULL
and	NULL
stimulated	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
NAC	NULL
constructs	NULL
contain	NULL
a	NULL
second	NULL
AC	NULL
unit	NULL
and	NULL
flanking	NULL
nucleotides	NULL
that	NULL
replaces	NULL
the	NULL
endogenous	NULL
IL-3	NULL
promoter	NULL
between	NULL
nt	NULL
-207	NULL
and	NULL
nt	NULL
-180	NULL
.	NULL

Data	NULL
from	NULL
two	NULL
independent	NULL
experiments	NULL
are	NULL
presented	NULL
as	NULL
outlined	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
stimulated	NULL
wild	NULL
type	NULL
-315-bp	NULL
IL-3	NULL
promoter	NULL
(	NULL
second	NULL
construct	NULL
)	NULL
is	NULL
the	NULL
reference	NULL
construct	NULL
in	NULL
this	NULL
experiment	NULL
and	NULL
has	NULL
a	NULL
relative	NULL
luciferase	NULL
activity	NULL
of	NULL
1.0.	NULL
factors	NULL
,	NULL
it	NULL
may	NULL
involve	NULL
alteration	NULL
in	NULL
DNA	NULL
configuration	NULL
via	NULL
bending	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
CBF	NULL
may	NULL
function	NULL
as	NULL
a	NULL
chaperon	NULL
protein	NULL
and	NULL
augment/inhibit	NULL
binding	NULL
of	NULL
other	NULL
proteins	NULL
to	NULL
the	NULL
promoter	NULL
.	NULL

For	NULL
example	NULL
,	NULL
several	NULL
isoforms	NULL
of	NULL
CBF	NULL
have	NULL
been	NULL
identified	NULL
and	NULL
found	NULL
to	NULL
have	NULL
variable	NULL
activity	NULL
in	NULL
vitro	NULL
(	NULL
24	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
capacity	NULL
of	NULL
CBF	NULL
to	NULL
modulate	NULL
the	NULL
association	NULL
between	NULL
other	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
the	NULL
Act-l-binding	NULL
proteins	NULL
,	NULL
and	NULL
DNA	NULL
may	NULL
be	NULL
dependent	NULL
on	NULL
the	NULL
relative	NULL
amount	NULL
of	NULL
the	NULL
various	NULL
CBF	NULL
isoforms	NULL
under	NULL
various	NULL
conditions	NULL
.	NULL

Previous	NULL
in	NULL
vivo	NULL
footprinting	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
is	NULL
consistent	NULL
with	NULL
this	NULL
hypothesis	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
protection	NULL
of	NULL
the	NULL
CBF	NULL
site	NULL
only	NULL
upon	NULL
stimulation	NULL
,	NULL
despite	NULL
similar	NULL
amounts	NULL
of	NULL
CBF	NULL
binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
obtained	NULL
from	NULL
either	NULL
stimulated	NULL
or	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
38	NULL
)	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
further	NULL
supported	NULL
by	NULL
recent	NULL
data	NULL
that	NULL
demonstrate	NULL
a	NULL
similar	NULL
functional	NULL
interdependence	NULL
between	NULL
PEBP2a	NULL
@	NULL
,	NULL
the	NULL
murine	NULL
homologue	NULL
of	NULL
CBF	NULL
,	NULL
and	NULL
Ets-1	NULL
,	NULL
which	NULL
binds	NULL
an	NULL
adjacent	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
a	NULL
chain	NULL
enhancer	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
AC	NULL
unit	NULL
contributes	NULL
to	NULL
the	NULL
specific	NULL
up-regulation	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
its	NULL
effect	NULL
on	NULL
a	NULL
minimal	NULL
promoter	NULL
,	NULL
the	NULL
full-length	NULL
(	NULL
-315	NULL
bp	NULL
)	NULL
IL-3	NULL
promoter	NULL
is	NULL
not	NULL
active	NULL
in	NULL
fibroblasts	NULL
.	NULL

Therefore	NULL
,	NULL
additional	NULL
elements	NULL
between	NULL
nt	NULL
-61	NULL
and	NULL
nt	NULL
-315	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
contribute	NULL
to	NULL
tissue-specific	NULL
promoter	NULL
activity	NULL
by	NULL
limiting	NULL
activity	NULL
in	NULL
non-T	NULL
cells	NULL
.	NULL

As	NULL
suggested	NULL
by	NULL
our	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
there	NULL
are	NULL
at	NULL
least	NULL
two	NULL
elements	NULL
that	NULL
inhibit	NULL
IL-3	NULL
promoter	NULL
activity	NULL
in	NULL
NIH3T3	NULL
cells	NULL
.	NULL

One	NULL
element	NULL
resides	NULL
between	NULL
nt	NULL
-173	NULL
and	NULL
nt	NULL
-315	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
this	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
is	NULL
also	NULL
associated	NULL
with	NULL
a	NULL
low	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

The	NULL
NIP	NULL
site	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
is	NULL
located	NULL
at	NULL
nt	NULL
-266	NULL
,	NULL
is	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
transcription	NULL
,	NULL
and	NULL
has	NULL
been	NULL
extensively	NULL
studied	NULL
in	NULL
this	NULL
laboratory	NULL
(	NULL
5	NULL
,	NULL
30	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
proximity	NULL
of	NULL
the	NULL
upstream	NULL
NIP	NULL
region	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
to	NULL
the	NULL
AP-1	NULL
(	NULL
nucleotide	NULL
-303	NULL
)	NULL
and	NULL
EIlf-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
14026	NULL
A	NULL
Act1	NULL
BF	NULL
(	NULL
OB	NULL
--	NULL
CLuciP	NULL
)	NULL
-180	NULL
CH	NULL
CLucif	NULL
)	NULL
Functional	NULL
Role	NULL
of	NULL
CBF	NULL
in	NULL
the	NULL
Regulation	NULL
of	NULL
Interleukin-3	NULL
§	NULL
Unstimulated	NULL
[	NULL
]	NULL
Stimulated	NULL
JKE6.1	NULL
Elf	NULL
1	NULL
API	NULL
g	NULL
:	NULL
NP	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Positive	NULL
regulatory	NULL
activity	NULL
maps	NULL
between	NULL
nt	NULL
-180	NULL
and	NULL
nt	NULL
-207	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
and	NULL
NIH3T3	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
promoter	NULL
constructs	NULL
and	NULL
stimulated	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Data	NULL
from	NULL
four	NULL
independent	NULL
experiments	NULL
are	NULL
presented	NULL
as	NULL
roo	NULL
forr	NULL
T-r-r	NULL
Tora	NULL
mT	NULL
Crd	NULL
0	NULL
-	NULL
02	NULL
04	NULL
Q6	NULL
o8	NULL
|	NULL
1	NULL
12	NULL
0	NULL
1.4	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
outlined	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
stimulated	NULL
B	NULL
Unstimulated	NULL
D	NULL
Stimulated	NULL
NIH3T3	NULL
-207-bp	NULL
IL-3	NULL
promoter	NULL
is	NULL
the	NULL
reference	NULL
construct	NULL
in	NULL
this	NULL
experiment	NULL
and	NULL
has	NULL
a	NULL
relative	NULL
luciferase	NULL
activity	NULL
of	NULL
1.0	NULL
.	NULL

CBF	NULL
-180	NULL
0	NULL
0.2	NULL
0.4	NULL
0.6	NULL
-	NULL
[	NULL
0.8I	NULL
i	NULL
1	NULL
i	NULL
l1.2	NULL
TaBuE	NULL
III	NULL
The	NULL
IL-3	NULL
promoter	NULL
contains	NULL
conserved	NULL
sequences	NULL
between	NULL
nt	NULL
-184	NULL
and	NULL
nt	NULL
-206	NULL
The	NULL
noncoding	NULL
strand	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
promoter	NULL
is	NULL
compared	NULL
with	NULL
both	NULL
AP-1/Act-1	NULL
sequences	NULL
(	NULL
IL3CK3a	NULL
)	NULL
and	NULL
the	NULL
NFAT	NULL
binding	NULL
sequence	NULL
found	NULL
in	NULL
either	NULL
the	NULL
intergenic	NULL
region	NULL
of	NULL
the	NULL
IL-3/GM-CSF	NULL
locus	NULL
or	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
IL3CK3b	NULL
)	NULL
.	NULL

-207	NULL
I	NULL
5'-TTAAGTAATCTTTTTTICTTGTITTICA-	NULL
-AATTCATTAGAAAAAAGAACAAAGT-S5	NULL
'	NULL
€	NULL
¢	NULL
--	NULL
--	NULL
_-____-	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
served	NULL
CK1/CK2	NULL
DNA	NULL
sequence	NULL
is	NULL
present	NULL
in	NULL
this	NULL
region	NULL
and	NULL
may	NULL
be	NULL
important	NULL
in	NULL
this	NULL
activity	NULL
,	NULL
since	NULL
a	NULL
concatamer	NULL
of	NULL
this	NULL
sequence	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
the	NULL
basal	NULL
transcription	NULL
of	NULL
a	NULL
heterologous	NULL
promoter	NULL
and	NULL
proteins	NULL
from	NULL
the	NULL
transcriptionally	NULL
active	NULL
Rel/NFxB	NULL
family	NULL
bind	NULL
to	NULL
the	NULL
CK1	NULL
element	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
combined	NULL
effect	NULL
of	NULL
these	NULL
two	NULL
negative	NULL
elements	NULL
is	NULL
abrogation	NULL
of	NULL
IL-3	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
context	NULL
of	NULL
NIHST3	NULL
cells	NULL
.	NULL

The	NULL
second	NULL
observation	NULL
resulting	NULL
from	NULL
the	NULL
study	NULL
of	NULL
the	NULL
AC	NULL
unit	NULL
,	NULL
and	NULL
immediately	NULL
relevant	NULL
to	NULL
IL-3	NULL
promoter	NULL
function	NULL
,	NULL
is	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
previously	NULL
unknown	NULL
positive	NULL
regulatory	NULL
IL3CK8a	NULL
IL3CK3b	NULL
region	NULL
between	NULL
nt	NULL
-180	NULL
and	NULL
nt	NULL
-207	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

This	NULL
region	NULL
of	NULL
the	NULL
Promoter	NULL
element	NULL
Sequence	NULL
IL-3	NULL
promoter	NULL
is	NULL
67-100	NULL
%	NULL
conserved	NULL
between	NULL
human	NULL
,	NULL
new	NULL
IL3	NULL
AP1	NULL
(	NULL
-303	NULL
)	NULL
TCAGTCA	NULL
world	NULL
.	NULL

monker	NULL
,	NULL
sheep	NULL
,	NULL
er1t	NULL
,	NULL
Iand	NULL
mice	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
IL3	NULL
Act-1	NULL
(	NULL
-155	NULL
)	NULL
ATCAATAATTACCTCTC	NULL
majority	NULL
of	NULL
differences	NULL
within	NULL
these	NULL
27	NULL
bp	NULL
represent	NULL
conserva-IL3	NULL
CK3a	NULL
TTACTTA	NULL
tive	NULL
changes	NULL
.	NULL

Preliminary	NULL
characterization	NULL
of	NULL
-180/-207	NULL
re-NFIL2E	NULL
(	NULL
-282NFAT	NULL
)	NULL
GGAGGAAAAACTGTTTCAT	NULL
gion	NULL
by	NULL
gel	NULL
shift	NULL
analysis	NULL
demonstrates	NULL
that	NULL
at	NULL
least	NULL
two	NULL
protein	NULL
GM550	NULL
(	NULL
NFAT-AP1	NULL
)	NULL
GAAAGGAGCAAAGCAAGAGTCAT	NULL
complexes	NULL
bind	NULL
independently	NULL
to	NULL
this	NULL
region	NULL
.	NULL

Although	NULL
there	NULL
IL3	NULL
CK3b	NULL
GAAACAAGAAAAAAGA	NULL
(	NULL
nucleotide	NULL
-288	NULL
)	NULL
elements	NULL
is	NULL
intriguing	NULL
.	NULL

The	NULL
latter	NULL
two	NULL
regions	NULL
are	NULL
known	NULL
positive	NULL
regulators	NULL
of	NULL
promoter	NULL
activity	NULL
,	NULL
and	NULL
EIf-1	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
specific	NULL
positive	NULL
regulation	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
AP-1-EIf-1-NIP	NULL
complex	NULL
may	NULL
represent	NULL
a	NULL
second	NULL
example	NULL
within	NULL
the	NULL
IL-3	NULL
promoter	NULL
of	NULL
a	NULL
functional	NULL
interdependence	NULL
between	NULL
adjacent	NULL
regulatory	NULL
regions	NULL
.	NULL

A	NULL
second	NULL
element	NULL
is	NULL
present	NULL
between	NULL
nt	NULL
-61	NULL
and	NULL
nt	NULL
-173	NULL
.	NULL

This	NULL
element	NULL
functionally	NULL
negates	NULL
the	NULL
positive	NULL
contribution	NULL
of	NULL
the	NULL
endogenous	NULL
AC	NULL
unit	NULL
,	NULL
which	NULL
is	NULL
evidenced	NULL
by	NULL
a	NULL
decrease	NULL
in	NULL
activity	NULL
of	NULL
the	NULL
-173-bp	NULL
promoter	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
-61-bp	NULL
promoter	NULL
containing	NULL
an	NULL
AC	NULL
unit	NULL
.	NULL

A	NULL
highly	NULL
con	NULL
are	NULL
sequence	NULL
similarities	NULL
between	NULL
the	NULL
noncoding	NULL
strand	NULL
of	NULL
this	NULL
region	NULL
and	NULL
the	NULL
Act-1/Oct-1	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFATp	NULL
sites	NULL
,	NULL
preliminary	NULL
experiments	NULL
suggest	NULL
that	NULL
these	NULL
factors	NULL
are	NULL
not	NULL
involved	NULL
in	NULL
binding	NULL
to	NULL
these	NULL
27	NULL
nucleotides	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
Oct-1	NULL
,	NULL
the	NULL
E4BP4	NULL
protein	NULL
,	NULL
NFIL3	NULL
,	NULL
binds	NULL
to	NULL
the	NULL
3	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
Act-1	NULL
site	NULL
(	NULL
6	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
3	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
Act-1	NULL
site	NULL
is	NULL
important	NULL
for	NULL
competition	NULL
of	NULL
CKS3a	NULL
binding	NULL
,	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
CK8a	NULL
site	NULL
contains	NULL
only	NULL
5	NULL
(	NULL
G'-ATTAC-	NULL
)	NULL
of	NULL
10	NULL
nucleotides	NULL
that	NULL
define	NULL
the	NULL
EABP4	NULL
consensus	NULL
site	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Antiserum	NULL
specific	NULL
for	NULL
the	NULL
NFIL3	NULL
protein	NULL
is	NULL
not	NULL
available	NULL
,	NULL
so	NULL
the	NULL
relationship	NULL
between	NULL
EABPA4/	NULL
NFIL3	NULL
and	NULL
the	NULL
observed	NULL
binding	NULL
at	NULL
the	NULL
CK38a	NULL
region	NULL
is	NULL
unknown	NULL
at	NULL
this	NULL
time	NULL
.	NULL

Regardless	NULL
,	NULL
a	NULL
more	NULL
complete	NULL
mutational	NULL
analysis	NULL
of	NULL
this	NULL
region	NULL
will	NULL
be	NULL
necessary	NULL
to	NULL
confirm	NULL
that	NULL
the	NULL
protein	NULL
complexes	NULL
identified	NULL
by	NULL
this	NULL
gel	NULL
shift	NULL
analysis	NULL
are	NULL
as	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Functional	NULL
Role	NULL
of	NULL
CBF	NULL
in	NULL
the	NULL
Regulation	NULL
of	NULL
Interleukin-3	NULL
A	NULL
i-	NULL
ut	NULL
<	NULL
ta	NULL
P	NULL
a	NULL
2	NULL
5	NULL
9	NULL
u	NULL
.	NULL

“	NULL
&	NULL
=	NULL
&	NULL
m	NULL
a	NULL
»	NULL
Pa	NULL
u	NULL
.	NULL

9	NULL
a	NULL
9	NULL
®	NULL
x	NULL
9	NULL
u	NULL
7	NULL
m	NULL
E	NULL
2	NULL
a	NULL
=	NULL
i	NULL
<	NULL
<	NULL
<	NULL
©	NULL
-g	NULL
API	NULL
-	NULL
-	NULL
>	NULL
-+	NULL
®	NULL
@	NULL
.	NULL

ABRS	NULL
<	NULL
<	NULL
CK3a	NULL
-	NULL
»	NULL
w.-t-	NULL
&	NULL
a.	NULL
nd	NULL
Io	NULL
&	NULL
CK3	NULL
I	NULL
u	NULL
&	NULL
p-E	NULL
i	NULL
.	NULL

<	NULL
C	NULL
<	NULL
hel	NULL
s	NULL
E0	NULL
&	NULL
9	NULL
5	NULL
=-	NULL
m	NULL
O	NULL
Ao	NULL
b	NULL
2	NULL
d	NULL
-	NULL
<	NULL
-	NULL
<	NULL
gmuee	NULL
gone	NULL
goon	NULL
CK3b	NULL
-	NULL
>	NULL
.	NULL

(	NULL
e®	NULL
CKBa	NULL
-o	NULL
»	NULL
-	NULL
lime	NULL
und	NULL
Wh	NULL
--	NULL
-CK3	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

The	NULL
IL-3	NULL
promoter	NULL
between	NULL
nt	NULL
-180	NULL
and	NULL
nt	NULL
-207	NULL
contains	NULL
two	NULL
protein	NULL
binding	NULL
regions	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
that	NULL
were	NULL
stimulated	NULL
for	NULL
6	NULL
h	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
TPA	NULL
and	NULL
ionomycin	NULL
.	NULL

A	NULL
,	NULL
the	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
competitor	NULL
oligonucleotide	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
and	NULL
one	NULL
of	NULL
three	NULL
probes	NULL
indicated	NULL
below	NULL
the	NULL
lane	NULL
.	NULL

API	NULL
,	NULL
tggggaaccetgtgcTGAGTCActggag	NULL
;	NULL
Msel-Sauda	NULL
,	NULL
TTAAGTAATCTTTTTTCTTGTTTCACT	NULL
;	NULL
or	NULL
CK3	NULL
,	NULL
agetTGAAA-CAAGAAAAAAGATTACTTAg	NULL
.	NULL

B	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
competitor	NULL
oligonucleotide	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
and	NULL
with	NULL
the	NULL
CK3	NULL
probe	NULL
.	NULL

Sequences	NULL
of	NULL
competitor	NULL
oligonucleotide	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
ILGNFAT	NULL
,	NULL
agetTGAAACAAGAAAAAAG	NULL
;	NULL
IL2NFAT	NULL
,	NULL
agettGAAAGGAG-GAAAAAg	NULL
;	NULL
ACT-CBF	NULL
,	NULL
gatectaatggATGAATAATTACGTCTGTGGTT-Tctagaget	NULL
;	NULL
Act	NULL
,	NULL
catggATGAATAATTACGTCTGca	NULL
;	NULL
Act-5	NULL
'	NULL
,	NULL
agettgeAT-GAATTAgagece	NULL
;	NULL
CBF	NULL
,	NULL
gatcACGTCTGTGGTTTTCTATG	NULL
.	NULL

Uppercase	NULL
letters	NULL
are	NULL
used	NULL
to	NULL
designate	NULL
nucleotides	NULL
corresponding	NULL
to	NULL
portions	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
.	NULL

Relevant	NULL
binding	NULL
sites	NULL
within	NULL
oligonucleotides	NULL
derived	NULL
from	NULL
exogenous	NULL
promoters	NULL
are	NULL
also	NULL
noted	NULL
in	NULL
uppercase	NULL
leffers	NULL
.	NULL

sociated	NULL
with	NULL
the	NULL
positive	NULL
regulatory	NULL
activity	NULL
.	NULL

These	NULL
studies	NULL
are	NULL
in	NULL
progress	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
Act-1	NULL
and	NULL
CBF	NULL
sites	NULL
14027	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
form	NULL
a	NULL
functional	NULL
unit	NULL
.	NULL

We	NULL
further	NULL
demonstrate	NULL
that	NULL
the	NULL
tissue-specific	NULL
activity	NULL
of	NULL
the	NULL
proximal	NULL
IL-3	NULL
promoter	NULL
results	NULL
from	NULL
the	NULL
combined	NULL
activity	NULL
of	NULL
this	NULL
unit	NULL
and	NULL
other	NULL
regulatory	NULL
elements	NULL
within	NULL
the	NULL
promoter	NULL
rather	NULL
than	NULL
from	NULL
a	NULL
single	NULL
,	NULL
tissue-specific	NULL
protein	NULL
.	NULL

The	NULL
contribution	NULL
of	NULL
the	NULL
Act-1/CBF	NULL
unit	NULL
to	NULL
this	NULL
activity	NULL
is	NULL
important	NULL
as	NULL
it	NULL
mediates	NULL
inducible	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
context	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
but	NULL
not	NULL
fibroblasts	NULL
)	NULL
.	NULL

It	NULL
remains	NULL
important	NULL
to	NULL
determine	NULL
how	NULL
,	NULL
or	NULL
whether	NULL
,	NULL
mutant	NULL
forms	NULL
of	NULL
the	NULL
CBF	NULL
protein	NULL
,	NULL
relevant	NULL
to	NULL
AML	NULL
and	NULL
MDS	NULL
,	NULL
alter	NULL
this	NULL
tissue-specific	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
the	NULL
recognized	NULL
association	NULL
of	NULL
the	NULL
M4Eo	NULL
subtype	NULL
of	NULL
AML	NULL
with	NULL
both	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
B-chain	NULL
of	NULL
CBF	NULL
and	NULL
eosinophilia	NULL
indirectly	NULL
suggests	NULL
that	NULL
IL-3	NULL
,	NULL
a	NULL
positive	NULL
regulator	NULL
of	NULL
eosinophil	NULL
differen-tiation	NULL
,	NULL
is	NULL
abnormally	NULL
up-regulated	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
A.	NULL
Rao	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
for	NULL
generously	NULL
providing	NULL
antiserum	NULL
and	NULL
Svetlana	NULL
Levin	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Metcalf	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17	NULL
,	NULL
286-289	NULL
2	NULL
.	NULL

Niemeyer	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Sieff	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Mathey-Prevot	NULL
,	NULL
B.	NULL
,	NULL
Bierer	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
and	NULL
Nathan	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
945-951	NULL
3	NULL
.	NULL

Cameron	NULL
,	NULL
S.	NULL
,	NULL
Taylor	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
TePas	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Mathey-Prevot	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Blood	NULL
88	NULL
,	NULL
2851-2859	NULL
4	NULL
.	NULL

Gottschalk	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Giannola	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Emerson	NULL
,	NULL
S.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178	NULL
,	NULL
1681-1692	NULL
5	NULL
.	NULL

Mathey-Prevot	NULL
,	NULL
B.	NULL
,	NULL
Andrews	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Murphy	NULL
,	NULL
H.	NULL
S.	NULL
,	NULL
Kreissman	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
and	NULL
Nathan	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
5046-5050	NULL
6	NULL
.	NULL

Shoemaker	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Hromas	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Kaushansky	NULL
,	NULL
K.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
9650-9654	NULL
7	NULL
.	NULL

Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Edwards	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
254	NULL
,	NULL
558-562	NULL
8	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Tokumitsu	NULL
,	NULL
H.	NULL
,	NULL
Tsuboi	NULL
,	NULL
A.	NULL
,	NULL
Shlomai	NULL
,	NULL
J.	NULL
,	NULL
Hung	NULL
,	NULL
P.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
7399-7407	NULL
9	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Chen	NULL
,	NULL
L.	NULL
,	NULL
Thomas	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Timmerman	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Admaon	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
869	NULL
,	NULL
497-502	NULL
10	NULL
.	NULL

Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Bert	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Ryan	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Vadas	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
2466-2470	NULL
11	NULL
.	NULL

Redondo	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Pfohl	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Hernandez-Munain	NULL
,	NULL
C.	NULL
,	NULL
Wang	NULL
,	NULL
S.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Krangel	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
4817-4823	NULL
12	NULL
.	NULL

Wang	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
Bassuk	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
1153-1159	NULL
13	NULL
.	NULL

Kozu	NULL
,	NULL
T.	NULL
,	NULL
Miyoshi	NULL
,	NULL
H.	NULL
,	NULL
Shimizu	NULL
,	NULL
K.	NULL
,	NULL
Maseki	NULL
,	NULL
N.	NULL
,	NULL
Kaneko	NULL
,	NULL
Y.	NULL
,	NULL
Asou	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Kamada	NULL
,	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
1270-1276	NULL
14	NULL
.	NULL

Miyoshi	NULL
,	NULL
H.	NULL
,	NULL
Shimizu	NULL
,	NULL
K.	NULL
,	NULL
Kozu	NULL
,	NULL
T.	NULL
,	NULL
Maseki	NULL
,	NULL
N.	NULL
,	NULL
Kaneko	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Ohki	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
10481-10484	NULL
15	NULL
.	NULL

Nucifora	NULL
,	NULL
G.	NULL
,	NULL
Begy	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Erickson	NULL
,	NULL
P.	NULL
,	NULL
Drabkin	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
and	NULL
Rowley	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
7784-7788	NULL
16	NULL
.	NULL

Nucifora	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Rowley	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
86	NULL
,	NULL
1-14	NULL
17	NULL
.	NULL

Liu	NULL
,	NULL
P.	NULL
,	NULL
Tarlé	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Hajra	NULL
,	NULL
A.	NULL
,	NULL
Claxton	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Marlton	NULL
,	NULL
P.	NULL
,	NULL
Freedman	NULL
,	NULL
M.	NULL
,	NULL
Siciliano	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Collins	NULL
,	NULL
F.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1041-1044	NULL
18	NULL
.	NULL

Davies	NULL
,	NULL
K.	NULL
,	NULL
TePas	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
Nathan	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
and	NULL
Mathey-Prevot	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Blood	NULL
81	NULL
,	NULL
928-934	NULL
19.	NULL
deWet	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Wood	NULL
,	NULL
K.	NULL
V.	NULL
,	NULL
DeLuca	NULL
,	NULL
M.	NULL
,	NULL
Helinski	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Subramani	NULL
,	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
725-737	NULL
20	NULL
.	NULL

Murphey	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Chrysogelos	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
BioTechniques	NULL
18	NULL
,	NULL
967-969	NULL
21	NULL
.	NULL

Farr	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Roman	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
920	NULL
22	NULL
.	NULL

Andrews	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
and	NULL
Faller	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
2499	NULL
23	NULL
.	NULL

Meyers	NULL
,	NULL
S.	NULL
,	NULL
Lenny	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
1974-1982	NULL
24	NULL
.	NULL

Takahashi	NULL
,	NULL
A.	NULL
,	NULL
Satake	NULL
,	NULL
M.	NULL
,	NULL
Yamaguchi-Iwai	NULL
,	NULL
Y.	NULL
,	NULL
Bae	NULL
,	NULL
S.-C.	NULL
,	NULL
Lu	NULL
,	NULL
J.	NULL
,	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Zhang	NULL
,	NULL
Y.	NULL
W.	NULL
,	NULL
Oka	NULL
,	NULL
N.	NULL
,	NULL
Aria	NULL
,	NULL
K.-i	NULL
.	NULL

,	NULL
and	NULL
Ito	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Blood	NULL
86	NULL
,	NULL
607-616	NULL
25	NULL
.	NULL

Zhang	NULL
,	NULL
W.	NULL
,	NULL
Zhang	NULL
,	NULL
J.	NULL
,	NULL
Kornuc	NULL
,	NULL
M.	NULL
,	NULL
Kwan	NULL
,	NULL
K.	NULL
,	NULL
Frank	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Nimer	NULL
,	NULL
S.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
6055-6063	NULL
26	NULL
.	NULL

Liu	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
Claxton	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Marlton	NULL
,	NULL
P.	NULL
,	NULL
Hajra	NULL
,	NULL
A.	NULL
,	NULL
Siciliano	NULL
,	NULL
J.	NULL
,	NULL
Freedman	NULL
,	NULL
M.	NULL
,	NULL
Chandrasekharappa	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Yanagisawa	NULL
,	NULL
K.	NULL
,	NULL
Stallings	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Collins	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
and	NULL
Siciliano	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
716-721	NULL
27	NULL
.	NULL

Parvin	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
McCormick	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Sharp	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Fisher	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
873	NULL
,	NULL
724-727	NULL
28	NULL
.	NULL

Levanon	NULL
,	NULL
D.	NULL
,	NULL
Negreanu	NULL
,	NULL
V.	NULL
,	NULL
Bernstein	NULL
,	NULL
Y.	NULL
,	NULL
Bar-Am	NULL
,	NULL
I.	NULL
,	NULL
Avivi	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Groner	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Genomics	NULL
28	NULL
,	NULL
425-432	NULL
29	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
King	NULL
,	NULL
C.	NULL
,	NULL
Kirshner	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Grossched	NULL
!	NULL

,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
995-1008	NULL
30	NULL
.	NULL

Engeland	NULL
,	NULL
K.	NULL
,	NULL
Andrews	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
and	NULL
Mathey-Prevot	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
24572-24579	NULL
31	NULL
.	NULL

Lai	NULL
,	NULL
J.-H.	NULL
,	NULL
Horvath	NULL
,	NULL
G.	NULL
,	NULL
Subleski	NULL
,	NULL
J.	NULL
,	NULL
Bruder	NULL
,	NULL
J.	NULL
,	NULL
Ghosh	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Tan	NULL
,	NULL
T.-H.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
4260-4271	NULL
32	NULL
.	NULL

Burger	NULL
,	NULL
H.	NULL
,	NULL
Wagemaker	NULL
,	NULL
G.	NULL
,	NULL
Leunissen	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
M.	NULL
,	NULL
and	NULL
Dorssers	NULL
,	NULL
L.	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Evol	NULL
.	NULL

89	NULL
,	NULL
255-267	NULL
33	NULL
.	NULL

Cowell	NULL
,	NULL
I.	NULL
G.	NULL
,	NULL
Skinner	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Hurst	NULL
,	NULL
H.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
3070-8077	NULL
34	NULL
.	NULL

Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Renjifo	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Hopkins	NULL
,	NULL
N.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

64	NULL
,	NULL
548-550	NULL
35	NULL
.	NULL

Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Renjifo	NULL
,	NULL
B.	NULL
,	NULL
Golemis	NULL
,	NULL
E.	NULL
,	NULL
Fredrickson	NULL
,	NULL
T.	NULL
N.	NULL
,	NULL
Hartley	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Hopkins	NULL
,	NULL
N.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
233-242	NULL
36	NULL
.	NULL

Prosser	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Wotton	NULL
,	NULL
D.	NULL
,	NULL
Gegonne	NULL
,	NULL
A.	NULL
,	NULL
Ghysdael	NULL
,	NULL
J.	NULL
,	NULL
Wang	NULL
,	NULL
S.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Owen	NULL
,	NULL
O.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
9934-9938	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Cooperation	NULL
between	NULL
Core	NULL
Binding	NULL
Factor	NULL
and	NULL
Adjacent	NULL
Promoter	NULL
Elements	NULL
Contributes	NULL
to	NULL
the	NULL
Tissue-specific	NULL
Expression	NULL
of	NULL
Interleukin-3	NULL
Douglas	NULL
S.	NULL
Taylor	NULL
,	NULL
Jacob	NULL
P.	NULL
Laubach	NULL
,	NULL
David	NULL
G.	NULL
Nathan	NULL
and	NULL
Bernard	NULL
Mathey-Prevot	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:14020-14027.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.24.14020	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/24/14020	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
36	NULL
references	NULL
,	NULL
28	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
4020	NULL
.full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

